KR102002790B1 - Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine - Google Patents

Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine Download PDF

Info

Publication number
KR102002790B1
KR102002790B1 KR1020170098912A KR20170098912A KR102002790B1 KR 102002790 B1 KR102002790 B1 KR 102002790B1 KR 1020170098912 A KR1020170098912 A KR 1020170098912A KR 20170098912 A KR20170098912 A KR 20170098912A KR 102002790 B1 KR102002790 B1 KR 102002790B1
Authority
KR
South Korea
Prior art keywords
recombinant
glycoprotein
gene
cell line
β3gnt2
Prior art date
Application number
KR1020170098912A
Other languages
Korean (ko)
Other versions
KR20180016952A (en
Inventor
김정회
이충근
곽찬영
Original Assignee
한국과학기술원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술원 filed Critical 한국과학기술원
Priority to PCT/KR2017/008521 priority Critical patent/WO2018030738A1/en
Publication of KR20180016952A publication Critical patent/KR20180016952A/en
Application granted granted Critical
Publication of KR102002790B1 publication Critical patent/KR102002790B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01206Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (2.4.1.206)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 폴리락토사민의 생합성에 관여하는 β3gnt2 유전자의 발현을 억제(녹다운)하거나 β3gnt2 유전자를 녹아웃시킨 세포주로부터 생산된 재조합 인간 유래 에리스로포이에틴에서 폴리락토사민의 감소를 확인, 그에 따른 N-글리칸의 삼중 및/또는 사중 안테나 구조 증가를 확인함으로써 당단백질의 반감기 증가 및 당단백질 효능에 긍정적인 역할이 가능함을 확인한 바, 본 발명의 방법을 통해 반감기를 증가시킨 재조합 당단백질의 제조가 가능함을 확인하였다.
The present invention relates to a method for confirming the reduction of polylactosamine in recombinant human erythropoietin produced from a cell line in which expression of β3gnt2 gene involved in biosynthesis of polylactosamine is inhibited (knocked down) or β3gnt2 gene is knocked out, It was confirmed that increasing the triplet and / or quadrupole antenna structure could increase the half-life of the glycoprotein and play a positive role in the glycoprotein efficacy. As a result, it was confirmed that the recombinant glycoprotein having an increased half-life could be produced by the method of the present invention .

Description

폴리락토사민 생합성 저해에 의한 N-결합 당쇄 안테나구조가 강화된 재조합 당단백질 제조방법{Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a recombinant glycoprotein having enhanced N-linked sugar chain structure by inhibiting biosynthesis of polylactosamine,

본 발명은 β3gnt2(UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) 유전자의 발현을 억제(knock-down), 또는 β3gnt2 유전자를 녹-아웃(knock-out)하는 단계를 통해 폴리락토사민의 생합성 억제함으로써 반감기가 증가된 당단백질(glycoproteins) 제조방법에 관한 것이다.The present invention relates to a method for inhibiting the expression of β3gnt2 (UDP-GlcNAc: betaGal beta-1,3-N-acetylglucosaminyltransferase 2) gene by knocking down the β3gnt2 gene or knocking out β3gnt2 gene, The present invention relates to a method for producing glycoproteins having an increased half-life by inhibiting the biosynthesis of cyamine.

당화(glycosylation)는 포유동물 세포에서 주요한 번역 후 수식에 해당되고, 두 분류, N- 및 O- 연결 당화로 나뉜다. N-연결 당화는 다수의 당단백질에서 Asn(Asn-X-Ser/Thr 모티프)에 부착되어 있다. 당화는 효소 활성, 단백질 안정성, 및 면역원성에 영향을 준다. Glycosylation corresponds to a major post-translational expression in mammalian cells, divided into two classes, N- and O-linked glycosylation. N-linked saccharides are attached to Asn (Asn-X-Ser / Thr motifs) in a number of glycoproteins. Glycation affects enzyme activity, protein stability, and immunogenicity.

뉴라민산(neuraminic acid; Neu)의 아실유도체의 총칭인 시알산(sialic acid)은 당화 과정에 요구되는 당전구체 구성의 필수 성분으로 지금까지 자연계에서 약 50 여종의 시알산이 부가된 당쇄 전구체들이 발견되었다. 시알산은 포유류에 있어서 세포간 상호작용, 세포 내의 시그널을 결정하는 전구체의 역할, 당단백질의 안정화 등 세포 내의 생물학적 현상에 중요한 역할을 한다. 시알산은 1936년 Blix에 의해 소 타액선(bovine salivary gland)의 뮤신(mucin)으로부터 최초로 분리되었고, 9개의 탄소로 구성되어 있으며 COOH- 기를 가지고 있는 산성당(acidic sugar)으로서 알려져 있다. 또한, 시알산은 치환기의 차이에 의해 23 종류의 시알산이 보고되어 있으며 이들은 생물종이나 조직에 특이적인 분포를 나타내고 있는 것으로 알려져 있다. 고등동물에서 시알산은 당단백질, 당지질, 올리고당 당쇄의 Gal, GlcNAc, GalNAc 및 시알산에 각각 특이적인 시알산 전이효소의 작용에 의해 α-글리코시드 결합으로 연결되어 있다.Sialic acid, a generic term for acyl derivatives of neuraminic acid (Neu), is an essential component of the sugar precursor composition required for the glycation process. Up to now, about 50 kinds of sialic acid-added sugar chain precursors have been found in nature . Sialic acid plays an important role in biological phenomena in cells such as intercellular interactions in mammals, the role of precursors to determine intracellular signals, and the stabilization of glycoproteins. Sialic acid was first isolated from the mucin of the bovine salivary gland by Blix in 1936 and is known as an acidic sugar consisting of 9 carbons and a COOH- group. In addition, sialic acid has been reported to have 23 kinds of sialic acid due to the difference in substituents, and they are known to exhibit a distribution specific to species or tissues. In higher animals, sialic acid is linked by an α-glycosidic bond by the action of a sialyltransferase specific for glycoproteins, glycolipids, Gal, GlcNAc, GalNAc and sialic acid of the oligosaccharide sugar chain, respectively.

복합당질 당쇄의 시알산은 세포막 표면에 존재하는 당쇄 구조에서 가장 말단에 위치하고 있기 때문에 세포와 세포외 환경과의 접촉에 직접적으로 관여하고 있을 것으로 예상되었고, 오래전부터 체액 중의 혈구세포나 당단백질의 수명이 시알산의 제거에 의해 단축되는 것으로 알려져 있다. 이러한 예로서 적혈구 세포막의 시알산이 제거되면(asialylation) 갈락토스가 세포 표면에 노출되어 쿱퍼(Kupffer) 세포 표면상의 갈락토스와 특이적으로 결합하는 수용체 렉틴(lectin)과 결합함으로써, 수용체 매개된 내포작용(receptor-mediated endocytosis)에 의해 순환계로부터 제거되며, 시알산이 제거된 아사이알로(asialo) 당단백질도 간세포(hepatocyte) 표면의 렉틴에 의해 결합되어 적혈구 세포와 비슷한 경로로 순환계로부터 제거된다. 또한, 시알로 결합을 가지는 당단백질인 알파-안티트립신(alpha-antitrypsin), 콜린에스테라제(cholinesterase), 융모성 고나도트로핀(chorionic gonadotropin), CTLA4Ig, 인자 Ⅷ(Factor Ⅷ), 감마-글루타밀트랜스퍼라아제(gamma-glutamyltransferase), 과립구 콜로니 자극인자(granulocyte colony-stimulating Factor, G-CSF) 및 황체형성호르몬(luteinizing hormone, LH)은 시알산이 결합된 당단백질의 경우 시알산이 결합되지 않은 것에 비해 당단백질의 반감기가 현저하게 증가하는 것으로 보고되었다(Ngantung FA. et al., 2006, Biotechnol. Bioeng 95(1), 106-119).Since the sialic acid of the complex saccharide sugar chain is located at the distal end of the sugar chain structure existing on the surface of the cell membrane, it is expected that it will be directly involved in the contact between the cell and the extracellular environment, and the lifespan of blood cells or glycoprotein It is known to be shortened by the removal of sialic acid. As an example of this, asialylation of erythrocyte membrane is achieved, galactose is exposed to the cell surface and binds to a receptor lectin that specifically binds to galactose on the surface of Kupffer cell to induce receptor mediated receptor -mediated endocytosis and sialic acid-removed asialo glycoprotein is also bound by lectin on the surface of the hepatocyte and removed from the circulatory system by a pathway similar to red blood cells. In addition, a glycoprotein having a sialo-linkage such as alpha-antitrypsin, cholinesterase, chorionic gonadotropin, CTLA4Ig, Factor VIII, gamma- Gamma-glutamyltransferase, granulocyte colony-stimulating factor (G-CSF) and luteinizing hormone (LH) have been shown to inhibit sialic acid- (Ngantung FA et al., 2006, Biotechnol. Bioeng 95 (1), 106-119).

시알로 결합을 가진 당단백질 중에서 에리스로포이에틴(erythropoietin, EPO)은 적혈구 생성을 유도하는 당단백질 호르몬으로서, 재조합 EPO는 빈혈치료제로 이용되고 있다. 야생형의 EPO는 N- 결합 당쇄 3개 및 O- 결합 당쇄 1개를 가지며, 하나의 N- 결합 당쇄에는 최대 4개의 시알산(sialic acid)이, 하나의 O- 결합 당쇄에는 최대 2개의 시알산이 결합할 수 있어서 잠재적으로 한 분자의 EPO는 총 14개의 시알산이 결합할 수 있다. 상기 당단백질과 마찬가지로 EPO 단백질에서 시알산이 당쇄에 결합되어 있는 경우, 간에 존재하는 탈시알로당단백수용체와의 결합을 막아 간에서 EPO가 분해되는 것을 방지한다. Erythropoietin (EPO) is a glycoprotein hormone that induces erythropoiesis, and recombinant EPO is used as an anemia drug. The wild-type EPO has three N-linked sugar chains and one O-linked sugar chain, with up to four sialic acids in one N-linked sugar chain and up to two sialic acids in one O- So that potentially one molecule of EPO can bind a total of 14 sialic acids. As in the case of the glycoprotein, when sialic acid is bound to the sugar chain in the EPO protein, it prevents the degradation of EPO in the liver by blocking binding with the deglycosylated glycoprotein receptor present in the liver.

폴리락토사민은 N-아세틸글루코사민(N-acetylglucosamine, GlcNAc)와 갈락토오스(Galactose)가 연속적으로 반복되는 구조(Galbeta1-4GlcNAcbeta1-3)n로 당단백질 상에 존재하는 당사슬의 기초 구조 중의 하나이다. 일례로 EPO 같은 모델당단백질에서 폴리락토사민은 전체 N-글리칸 중 약 10 내지 20%를 차지하는데 마우스를 이용한 실험에서 폴리락토사민이 포함된 EPO는 상기 시알산에 의한 당단백질의 표면상의 갈락토오스 보호 효과와 무관하게 체내 반감기가 현저히 감소한다는 것이 보고 되었다.Polylactosamine is one of the basic structures of oligosaccharides present on glycoproteins as N-acetylglucosamine (GlcNAc) and galactose (Galbeta1-4GlcNAcbeta1-3) n in which the galactose is repeated continuously. For example, in a model glycoprotein such as EPO, polylactosamine accounts for about 10 to 20% of the total N-glycans. In the experiment using mice, EPO containing polylactosamine was found to contain galactose on the surface of the glycoprotein It has been reported that the half-life of the body is significantly reduced regardless of the protective effect.

Figure 112017075361127-pat00001
Figure 112017075361127-pat00001

(그림 1. 폴리락토사민의 구조적 특징)(Figure 1. Structural characteristics of polylactosamine)

1970년대 DNA의 특정 서열을 인지해 자르는 제한효소가 발견될 것을 시작으로 유전자 조작기술은 시대에 시대를 거듭하여 급격하게 발전해 왔다. 하지만 제한효소를 활용한 유전자 조작기술은 그 한계가 명확했다. 구체적으로, 제한효소는 6~8 개 정도의 인식할 수 있는 유전자 서열의 길이가 매우 짧아, 약 46(4,096) 개의 순서쌍 밖에 구분하지 못하는 문제가 존재했다. 반면에 CRISPR/CAS9 시스템은 이러한 한계가 없어 이론적으로 인간 이상의 고등 생명체에도 적용 가능하다.Since the discovery of restriction enzymes that recognize and cut specific sequences of DNA in the 1970s, genetic engineering techniques have developed rapidly over time. However, the limitation of gene manipulation technology using restriction enzymes was clear. Specifically, the restriction enzyme has a short length of about 6 to 8 recognizable gene sequences, and there is a problem that only about 46 (4,096) ordered pairs can be distinguished. The CRISPR / CAS9 system, on the other hand, does not have this limitation and is theoretically applicable to higher life than human beings.

CRISPR/CAS9 시스템은 크리스퍼(Clustered regularly interspaced short palindromic repeat, CRISPR) 유전자 가위라 불리는 게놈 편집 방법으로, 특정 염기서열에 특이적으로 결합하는 RNA(gRNA)와 특정한 염기서열을 자르는 가위 역할인 Cas9 nuclease로 구성된다. 이러한 CRISPR/CAS9 시스템을 이용하면 세포나 동물에 플라스미드(Plasmid) DNA를 도입하여 특정 유전자의 기능을 억제할 수 있는 녹-아웃(knock-out)이 가능하다. The CRISPR / CAS9 system is a genome editing method called a clustered regularly interspaced short palindromic repeat (CRISPR) gene scissors. It uses RNA (gRNA) that specifically binds to a specific nucleotide sequence and Cas9 nuclease . Using such a CRISPR / CAS9 system, it is possible to knock-out plasmids into cells or animals to inhibit the function of specific genes.

CRISPR/CAS9 시스템은 불과 몇 년 전에 과학자들에 의해 발견된 것으로, 박테리아 등 단세포 유기체가 박테리오파지로부터 스스로를 지키는 아주 오래된 방법이다. 유기체가 박테리오파지의 DNA를 잘라 자신의 유전자에 붙여 기억하여 적응면역을 통해 살아남는 것으로 수백만 년에 걸쳐 진화되었고, 이것이 연구실에서 유기체의 DNA를 빠르게 편집할 수 있는 간단하고 명쾌한 방법으로 연구되었다. 구체적으로, 본래의 CRISPR/CAS9 시스템은 박테리아가 이전에 침입했던 바이러스의 DNA 일부를 자신의 유전체에 저장해둔 후, 바이러스가 침입할 때에 그 정보를 다시 꺼내어 바이러스 DNA만을 찾아 절단하는 데 쓰는 박테리아의 자기보호 메커니즘이다. 이를 유전체공학에 이용함으로써, 특정 유전자의 염기서열을 찾아가는 시발체(Primer)를 제작해 절단 효소인 Cas9 효소와 짝을 이루어 표적이 되는 DNA 염기서열에 달라붙어 DNA 절단이 일어난다. 따라서 DNA 복원(수선) 과정에서 돌연변이가 발생하게 된다.The CRISPR / CAS9 system was discovered by scientists only a few years ago, and is a very old way of organisms, such as bacteria, that keep themselves from bacteriophages. An organism has evolved over millions of years by cutting out the bacteriophage DNA, sticking it to its own gene, remembering it, and surviving through adaptive immunity, which has been studied in a simple and clear way to quickly edit the organism's DNA in the lab. Specifically, the original CRISPR / CAS9 system stores a portion of the DNA of a virus previously infected by the bacteria in its own genome, then retrieves the information again when the virus invades, Protection mechanism. By using it in genome engineering, a primer that searches for the base sequence of a specific gene is made and paired with the enzyme Cas9, which is a cleavage enzyme, to cling to the target DNA sequence to cause DNA cleavage. Therefore, mutation occurs in DNA repair (repair) process.

이에 본 발명자들은 당단백질의 분해 저항성을 높여, 체내 활성을 높이기 위한 방법으로 당단백질에서 폴리락토사민(polylactosamine)의 함량을 줄이기 위해 siRNA를 이용하여 폴리락토사민 합성에 관여하는 유전자를 녹-다운(knock-down)시킨 CHO 세포주, 및 CRISPR/CAS9 시스템을 이용하여 폴리락토사민 합성에 관여하는 유전자를 녹-아웃(knock-out)시킨 CHO 세포주를 구축하였으며, 이로부터 생산된 당단백질은 폴리락토사민 감소에 따라 삼중(Tri-) 및/또는 사중 안테나(Tetra-antennary) 구조가 증가하였고, 이로 인한 당단백질의 반감기 증가는 당단백질의 효능에 긍정적인 역할을 할 수 있음을 확인함으로써 본 발명을 완성하였다. Accordingly, the present inventors have conducted intensive studies to increase the resistance to degradation of glycoprotein and increase the activity of the glycoprotein by using the siRNA to reduce the content of polylactosamine in the glycoprotein, thereby rusting down the gene involved in polylactosamine synthesis knocked-down CHO cell line, and a CRISPR / CAS9 system. The resulting glycoprotein was knocked out with a gene involved in polylactosamine synthesis, and the resulting glycoprotein was polylactosamine Tri- and / or tetra-antennary structures were increased according to the decrease in the half-life of the glycoprotein, and it was confirmed that the increase of the half-life of the glycoprotein could play a positive role in the efficacy of the glycoprotein. Respectively.

본 발명의 목적은 폴리락토사민의 생합성이 억제된 세포주로부터 반감기가 증가된 당단백질의 제조방법을 제공하는 것이다.It is an object of the present invention to provide a method for producing a glycoprotein having increased half-life from a cell line inhibited by biosynthesis of polylactosamine.

상기 목적을 달성하기 위하여, 본 발명은 당단백질을 생성하는 세포주에서 폴리락토사민(Polylactosamine)의 생합성을 억제시키는 단계를 포함하는, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법을 제공한다.In order to accomplish the above object, the present invention provides a method for producing a recombinant cell line producing a recombinant glycoprotein with an increased half-life, comprising the step of inhibiting biosynthesis of polylactosamine in a cell line producing a glycoprotein do.

또한, 본 발명은 상기 방법으로 제조된 재조합 세포주를 제공한다.The present invention also provides a recombinant cell line produced by the above method.

또한, 본 발명은 In addition,

1) 상기 재조합 세포주를 배양하는 단계; 및1) culturing the recombinant cell line; And

2) 상기 단계 1)의 배양액에서 재조합 당단백질을 분리하는 단계를 포함하는 반감기가 증가된 재조합 당단백질의 제조방법을 제공한다.2) separating the recombinant glycoprotein from the culture medium of step 1).

또한, 본 발명은 상기 방법으로 분리된, 반감기가 증가된 재조합 당단백질을 제공한다.In addition, the present invention provides recombinant glycoproteins with increased half-life, separated by the above method.

아울러, 본 발명은 서열번호 10 내지 13으로 구성된 군으로부터 선택되는 어느 하나의 가이드 RNA를 암호화하는 염기서열; 및 서열번호 14로 기재되는 염기서열로 구성되는 Cas9 유전자를 포함하는, 재조합 벡터를 제공한다.In addition, the present invention provides a nucleic acid molecule comprising a nucleotide sequence encoding any one of the guide RNAs selected from the group consisting of SEQ ID NOS: 10 to 13; And a Cas9 gene consisting of the nucleotide sequence shown in SEQ ID NO: 14.

본 발명은 폴리락토사민의 생합성에 관여하는 β3gnt2 유전자의 발현을 억제(녹다운)하거나 β3gnt2 유전자를 녹아웃시킨 세포주로부터 생산된 재조합 인간 유래 에리스로포이에틴에서 폴리락토사민의 감소를 확인, 그에 따른 N-글리칸의 삼중 및/또는 사중 안테나 구조 증가를 확인함으로써 당단백질의 반감기 증가 및 당단백질 효능에 긍정적인 역할이 가능함을 확인한 바, 본 발명의 방법을 통해 반감기를 증가시킨 재조합 당단백질의 제조가 가능함을 확인하였다.The present invention relates to a method for confirming the reduction of polylactosamine in recombinant human erythropoietin produced from a cell line in which expression of β3gnt2 gene involved in biosynthesis of polylactosamine is inhibited (knocked down) or β3gnt2 gene is knocked out, It was confirmed that increasing the triplet and / or quadrupole antenna structure could increase the half-life of the glycoprotein and play a positive role in the glycoprotein efficacy. As a result, it was confirmed that the recombinant glycoprotein having an increased half-life could be produced by the method of the present invention .

도 1은, CHO 세포 내 폴리락토사민 합성 유전자 후보군(β3gnt 1∼9)의 발현 양상을 비교한 도이다.
도 2는, β3gnt2의 발현 억제(knock-down)를 위한 siRNA의 위치 및 서열을 나타낸 도이다.
도 3은, siRNA-1, siRNA-2 및 siRNA-3에 의한 유전자 발현 양상 및 그에 따른 웨스턴 블로팅 결과를 통해 siRNA 후보군 중 siRNA-2를 선정한 결과를 확인한 도이다:
도 3a: siRNA-1, siRNA-2 및 siRNA-3에 의한 유전자 발현 양상 확인 결과;
도 3b: siRNA-1, siRNA-2 및 siRNA-3에 의한 웨스턴 블로팅 결과;
도 3c: siRNA-2에 의한 웨스턴 블로팅 결과;
도 3d: siRNA-2에 의한 웨스턴 블로팅의 상대적 강도 확인 결과.
도 4는, siRNA-2에 의한 폴리락토사민 억제에 의한 당쇄 구조의 정량적 변화를 확인한 도이다:
도 4a: siRNA-2에 의한 폴리락토사민 비율 감소 확인;
도 4b: siRNA-2에 의한 삼중(Tri-) 및 사중 안테나(Tetra-antennary) N-글리칸의 증가 확인.
도 5는, siRNA-2에 의한 폴리락토사민 Glycan 구조들의 전체적인 프로파일 확인을 위한 MALDI-TOF MS 결과이다.
도 6은, siRNA-2에 의한 폴리락토사민 구조의 정량적 변화 확인을 위한 LC/MS 결과이다.
도 7은, gRNA-1, gRNA-2, gRNA-3 및 gRNA-4에 의해 β3gnt2의 녹-아웃(knock-out)된 결과를 나타낸 도이다:
도 7a: CRISPR/Cas9 시스템을 이용한 벡터의 개열 지도;
도 7b: T7 Endonuclease 1(T7E1) 어세이 후, 아가로스 겔 결과;
도 7c: T7 Endonuclease 1(T7E1) 어세이 후, 유전자의 삽입/결실 빈도(Indel) 결과(gRNA-1: 1, gRNA-2: 2, gRNA-3: 3, gRNA-4: 4).
도 8은, CRISPR/Cas9 시스템을 통해 β3gnt2 유전자가 녹아웃된 성공적으로 형질전환된 클론 선택 결과를 나타낸 도이다(1= gRNA-1, 2= gRNA-2, 3= gRNA-3, 4= gRNA-4):
도 8a: 유동세포계측법(Flow cytometry) 수행 결과;
도 8b: 대조군(WT)과 비교해서 인델(indel)이 확인된 클론들을 선별한 후 생거-시퀀싱(sanger-sequencing) 결과(삭제, 삽입 및 PAM 서열(GGC, AGG, CCC, CCT)).
도 9는, β3gnt2의 녹-아웃을 통한 폴리락토사민의 발현 감소 확인한 도이다:
도 9a: 선택된 클론(클론 1: gRNA-1의 9 / 클론 2: gRNA-4의 2 / 클론 3: gRNA-4의 12 / 클론 4: gRNA-4의 16)의 웨스턴 블로팅;
도 9b: 폴리락토사민 비율 감소 확인;
도 9c: 삼중(Tri-) 및 사중 안테나(Tetra-antennary) N-글리칸의 증가 확인.
Brief Description of the Drawings Fig. 1 compares the expression patterns of polylactosamine synthesis gene candidate groups (? 3gnt 1-9) in CHO cells.
Fig. 2 is a diagram showing the position and sequence of siRNA for knockdown of? 3 gnt2.
FIG. 3 is a graph showing the result of selecting siRNA-2 among candidate siRNAs based on gene expression patterns by siRNA-1, siRNA-2 and siRNA-3 and Western blotting results thereof:
Fig. 3a: Results of gene expression analysis by siRNA-1, siRNA-2 and siRNA-3;
Figure 3b: Western blotting results with siRNA-1, siRNA-2 and siRNA-3;
Figure 3c: Western blotting results with siRNA-2;
Figure 3d: Results of the relative intensities of western blotting by siRNA-2.
Fig. 4 is a diagram showing a quantitative change in sugar chain structure due to inhibition of polylactosamine by siRNA-2:
4a: confirmation of reduction of polylactosamine ratio by siRNA-2;
Figure 4b: Confirmation of the increase of tri- and tetra-antennary N-glycans by siRNA-2.
Figure 5 shows MALDI-TOF MS results for the overall profile identification of polylactosamine Glycan structures by siRNA-2.
Fig. 6 shows LC / MS results for confirming the quantitative change of the polylactosamine structure by siRNA-2. Fig.
7 is a diagram showing knock-out results of? 3gnt2 by gRNA-1, gRNA-2, gRNA-3 and gRNA-4:
7a: cleavage map of vector using CRISPR / Cas9 system;
Figure 7b: Agarose gel results after T7 Endonuclease 1 (T7E1) assay;
Fig. 7c: Results of gene insertion / deletion indent (gRNA-1: 1, gRNA-2: 2, gRNA-3: 3, gRNA-4: 4) after T7 Endonuclease 1 (T7E1) assay.
Fig. 8 shows the results of successful transformation of cloned β3gnt2 gene knockout through CRISPR / Cas9 system (1 = gRNA-1, 2 = gRNA-2, 3 = gRNA- 4):
8a: Flow cytometry results;
Figure 8b: Sanger-sequencing results (deletion, insertion and PAM sequences (GGC, AGG, CCC, CCT) after screening of indel-confirmed clones as compared to the control (WT).
9 is a view for confirming the decrease in the expression of polylactosamine through the r-out of? 3gnt2:
Western blotting of selected clones (clone 1: 9 of gRNA-1/2 of clone 2: 2 of gRNA-4: 12 of gRNA-4/16 of clone 4 of gRNA-4)
Figure 9b: Confirmation of the reduction of the polylactosamine ratio;
FIG. 9c: Tri- and tetra-antennary N-glycan ascertainment.

이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.

본 발명은 당단백질을 생성하는 세포주에서 폴리락토사민(Polylactosamine)의 생합성을 억제시키는 단계를 포함하는, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법을 제공한다.The present invention provides a method of producing a recombinant cell line producing a recombinant glycoprotein with an increased half-life, which comprises inhibiting biosynthesis of polylactosamine in a cell line producing a glycoprotein.

상기 당단백질은 에리스로포이에틴(erythropoietin), 트롬보포이에틴(thrombopoietin), 알파-안티트립신(alpha-antitrypsin), 콜린에스테라제(cholinesterase), 융모성 고나도트로핀(chorionic gonadotropin), CTLA4Ig, Factor Ⅷ, 감마-글루타밀트랜스퍼라아제(gamma-glutamyltransferase), 과립구 콜로니 자극인자(granulocyte colony-stimulating Factor, G-CSF) 및 황체형성호르몬(luteinizing hormone, LH)으로 구성된 군으로부터 선택되는 어느 하나인 것일 수 있으며, 구체적으로는 에리스로포이에틴일 수 있으나, 이에 한정되지 않는다. The glycoprotein may be selected from the group consisting of erythropoietin, thrombopoietin, alpha-antitrypsin, cholinesterase, chorionic gonadotropin, CTLA4Ig, Factor VIII , Gamma-glutamyltransferase, granulocyte colony-stimulating factor (G-CSF), and luteinizing hormone (LH). Specifically erythropoietin, but is not limited thereto.

상기 폴리락토사민의 생합성 억제를 위해서 구체적으로는 β3gnt2(UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) 유전자의 발현을 녹-다운(knock-down)시키거나, β3gnt2 유전자를 녹-아웃(knock-out)시키는 단계를 포함하는 것일 수 있다.Specifically, the expression of β3gnt2 (UDP-GlcNAc: betaGal beta-1,3-N-acetylglucosaminyltransferase 2) gene is knocked down or the β3gnt2 gene is knocked down to inhibit biosynthesis of polylactosamine. And a step of knocking out the signal.

상기 β3gnt2 유전자의 mRNA는 서열번호 1로 기재되는 염기서열로 구성될 수 있다. The mRNA of the? 3gnt2 gene may be composed of the nucleotide sequence shown in SEQ ID NO: 1.

상기 β3gnt2 유전자 발현의 녹-다운은, 구체적으로 β3gnt2 유전자 억제제를 처리하거나, 또는 β3gnt2 mRNA에 결합하는 안티센스 뉴클레오티드, siRNA, shRNA 및 miRNA로 구성된 군으로부터 선택되는 어느 하나를 당단백질을 생산하는 세포주에 형질감염시키는 것일 수 있으며, 더욱 구체적으로는 β3gnt2 mRNA에 결합하는 siRNA를 당단백질을 생산하는 세포주에 형질감염시키는 것일 수 있다.Specifically, the β3gnt2 gene inhibitor is degraded, or the antisense nucleotide, siRNA, shRNA, and miRNA binding to β3gnt2 mRNA are treated with the gene for the expression of β3gnt2 gene in a cell line producing the glycoprotein And more specifically, to transfect a cell line producing a glycoprotein with an siRNA binding to? 3gnt2 mRNA.

상기 siRNA는 서열번호 2, 서열번호 4 및 서열번호 6으로 구성된 군으로부터 선택되는 어느 하나의 염기서열을 포함할 수 있으나, 이에 한정되지 않는다. The siRNA may include any one selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 6, but is not limited thereto.

상기 siRNA는 상기 표적서열에 상동인 독립적인 센스 RNA 가닥 및 이에 상보적인 안티센스 RNA 가닥을 포함하거나 상기 센스 RNA 가닥 및 안티센스 RNA 가닥이 루프에 의해 연결된 스템-루프 구조의 단일 RNA 가닥일 수 있다.The siRNA may comprise an independent sense RNA strand homologous to the target sequence and a complementary antisense RNA strand or a single RNA strand of a stem-loop structure in which the sense RNA strand and the antisense RNA strand are connected by a loop.

상기 siRNA는 RNA끼리 짝을 이루는 이중사슬 RNA 부분이 완전히 쌍을 이루는 것에 한정되지 않고, 스템-루프(stem-loop)의 구조를 이루는 헤어핀 구조를 가질 수 있는데, 이를 특히 shRNA(short hairpin RNA)라 지칭한다. 한편, 상기 이중사슬 또는 스템 부위는 미스매치(대응하는 염기가 상보적이지 않음), 벌지(일방의 사슬에 대응하는 염기가 없음) 등에 의하여 쌍을 이루지 않는 부분이 포함될 수도 있다. 전체 길이는 10 내지 80 염기, 바람직하게는 15 내지 60 염기, 더욱 바람직하게는 20 내지 40 염기이다. 또한, 상기 루프 영역은 서열에 특별한 의미가 없으며, 단지 센스서열과 안티센스서열을 적당한 간격으로 연결하기 위하여 3-10 정도의 염기를 가지고 있으면 족하다. 종래에 siRNA의 루프 영역으로 많이 사용되어온 예들은 다음과 같다: AUG(Sui et al., Proc. Natl. Acad. Sci. USA 99(8):5515-5520, 2002), CCC, CCACC 또는 CCACACC(Paul et al., Nature Biotechnology 20:505-508, 2002), UUCG(Lee et al., Nature Biotechnology 20:500-505), CTCGAG, AAGCUU(Editors of Nature Cell Biology Whither RNAi, Nat Cell Biol. 5:489-490, 2003), UUCAAGAGA(Yu et al., Proc. Natl. Acad. Sci. USA 99(9):6047-6052, 2002) 및 TTGATATCCG(www.genscript.com의 default spacer). siRNA 말단 구조는 평활(blunt)말단 혹은 점착(cohesive) 말단 모두 가능하다. 점착 말단 구조는 3' 말단 돌출한 구조(protruding structure)와 5' 말단 쪽이 돌출한 구조가 모두 가능하고 돌출하는 염기 수는 한정되지 않는다. 예를 들어, 염기 수로는 1 내지 8 염기, 바람직하게는 2 내지 6 염기로 할 수 있다. 또한, siRNA는 표적유전자의 발현억제 효과를 유지할 수 있는 범위에서 예를 들어, 한쪽 말단의 돌출 부분에 저분자 RNA(예를 들어, tRNA, rRNA, 바이러스 RNA와 같은 천연의 RNA분자 또는 인공의 RNA분자)를 포함할 수 있다. siRNA 말단구조는 양측 모두 절단 구조를 가질 필요는 없고, 이중사슬 RNA의 일방의 말단 부위가 링커 RNA에 의하여 접속된 스템 루프형 구조일 수도 있다. 링커의 길이는 스템 부분의 쌍을 이루는 데 지장이 없는 길이면 특별히 한정되지 않는다.The siRNA is not limited to a complete pair of double-stranded RNAs paired with each other, and may have a hairpin structure that forms a stem-loop structure. Specifically, the siRNA may be a short hairpin RNA Quot; On the other hand, the double-chain or stem portion may include a non-paired portion due to a mismatch (the corresponding base is not complementary), a bulge (no base corresponding to one chain), or the like. The total length is 10 to 80 bases, preferably 15 to 60 bases, more preferably 20 to 40 bases. In addition, the loop region has no special significance in the sequence, and it is enough to have about 3-10 bases in order to connect the sense sequence and the antisense sequence at appropriate intervals. Previously used examples of siRNA loop regions were as follows: AUG (Sui et al., Proc. Natl. Acad Sci USA 99 (8): 5515-5520, 2002), CCC, CCACC or CCACACC (Nature et al., Nature Biotechnology 20: 505-508, 2002), UUCG (Lee et al., Nature Biotechnology 20: 500-505), CTCGAG, AAGCUU (Editors of Nature Cell Biology Whither RNAi, Nat Cell Biol. USA 99 (9): 6047-6052, 2002) and TTGATATCCG (default spacer at www.genscript.com). The siRNA termini are both blunt or cohesive termini. The sticky end structure can be a protruding structure with a 3 'end and a protruding structure with a 5' end, and the number of protruding bases is not limited. For example, the base water may be from 1 to 8 bases, preferably from 2 to 6 bases. In addition, the siRNA can be added to a protruding portion of one end in a range where the effect of suppressing the expression of the target gene can be maintained, for example, a small RNA (for example, a natural RNA molecule such as tRNA, rRNA, ). The siRNA terminal structure does not need to have a cleavage structure on both sides, and a stem loop structure in which one terminal region of double-stranded RNA is connected by linker RNA may be used. The length of the linker is not particularly limited as long as it does not interfere with the pairing of the stem portions.

더불어, 본 발명에 따른 siRNA에서, 센스 RNA 가닥 및/또는 안티센스 RNA가닥은 이의 당 부분, 뉴클레오베이스 부분 또는 인터뉴클레오타이드 구조 내에 최소한 1개의 화학적 변형을 포함하는 것이 가능하다. 이러한 변형은 생체 내에서 뉴클레아제에 의해 siRNA의 파괴를 저해하는 것을 가능하게 할 수 있다. 본 발명에 따른 siRNA의 안정성과 생적합성을 생체 내에서 향상시킬 수 있는 모든 화학적 변형이 본 발명의 범위에 포함된다. 당 부분 에 대한 바람직한 변형 중에서, 언급될 수 있는 것은 2'-데옥시, 2'-플루오로, 2'-아미노, 2'-티오, 또는 2'-O-알킬과 같은 리보오스의 포지션 2', 그리고 바람직하게는 리보뉴클레오타이드 상의 정상 2'-OH 그룹을 대체하는 2'-O-메틸 또는 LNA의 포지션 2' 및 4' 사이에 있는 메틸렌 브릿지의 존재에서 일어나는 변형이다. 뉴클레오베이스의 경우, 5-브로모-유리딘, 5-이오도-유리딘, N3-메틸-유리딘, 2,6-디아미노퓨린(DAP, 5-메틸-2'-데옥시시티딘, 5-(1-프로피닐)-2'-데옥시-유리딘(pdU), 5-(1-프로피닐)-2'-데옥시시티딘(pdC)과 같은 변형된 염기 또는 콜레스테롤과 결합한 염기를 이용하는 것이 가능하다. 마지막으로, 인터뉴클레오타이드 골격의 바람직한 변형은 포스포로티오에이트(phosphorothioate), 메틸포스포네이트, 포스포로디아미데이트 그룹에 의한 골격에 있는 포스포디에스터 그룹을 치환하는 것을 포함하거나, 펩타이드 결합에 의해 연결된 N-(2-아미노에틸)-글리신(PNA, 펩타이드 핵산)으로 구성되는 골격을 이용한다. 다양한 변형(염기, 당, 골격)은 몰포리노(morpholino) 타입의 변형된 핵산(몰포린 링에 고정되고 포스포로디아미데이트 그룹에 의해 연결된 염기) 또는 PNA(펩타이드 결합에 의해 연결된 N-(2-아미노에틸)-글리신 단위에 고정된 염기)에 결합될 수 있다.In addition, in an siRNA according to the invention, it is possible for the sense RNA strand and / or the antisense RNA strand to comprise at least one chemical modification in its sugar moiety, nucleobase moiety or internucleotide structure. Such modifications can make it possible to inhibit the destruction of siRNA by nuclease in vivo. All chemical modifications that can improve the stability and biocompatibility of siRNA according to the present invention in vivo are within the scope of the present invention. Of the preferred modifications to the sugar moieties, mention may be made of positions 2 ', 2'-fluoro, 2'-amino, 2'-thio, or 2'- And preferably in the presence of 2'-O-methyl replacing the normal 2'-OH group on the ribonucleotide or in the presence of methylene bridges between positions 2 'and 4' of the LNA. In the case of nucleobases, 5-bromo-uridine, 5-iodo-uridine, N3-methyl-uridine, 2,6-diaminopurine (DAP, 5-methyl-2'-deoxycytidine , Modified bases such as 5- (1-propynyl) -2'-deoxy-uridine (pdU), 5- (1-propinyl) -2'-deoxycytidine (pdC) Finally, a preferred modification of the internucleotide backbone involves the substitution of a phosphodiester group in the backbone by phosphorothioate, methylphosphonate, and phosphorodiamidate groups. (Base, sugar, skeleton) composed of N- (2-aminoethyl) -glycine (PNA, peptide nucleic acid) linked by a peptide bond. (A base that is immobilized on the morpholine ring and linked by a phosphorodiamidate group) or PNA (a peptide A base immobilized on an N- (2-aminoethyl) -glycine unit linked by a bond).

상기 형질감염은 리포펙타민(Lipofectamine), Dojindo사의 Hilymax, Fugene, jetPEI, Effectene 및 DreamFect으로 이루어진 군으로부터 선택되는 어느 하나의 상용화된 형질도입용 시약; 칼슘-인산(calcium-phosphate), 양전하성 고분자, 리포좀, 나노입자, 뉴클레오펙션(nucleofection), 전기천공법(electroporation), 열충격(heatshock), 마그네토펙션(magnetofection)을 이용하는 방법을 이용하는 방법으로 이루어진 군으로부터 선택되는 어느 하나를 이용하여 수행될 수 있다.Wherein the transfection is selected from the group consisting of Lipofectamine, Hilymax, Fugene, jetPEI, Effectene, and DreamFect from Dojindo, a commercialized transfection reagent; A method using a method using calcium-phosphate, a positively charged polymer, a liposome, a nanoparticle, a nucleofection, an electroporation, a heat shock, and a magnetofection May be performed using any one selected from the group consisting of < RTI ID = 0.0 >

상기 β3gnt2 유전자의 녹-아웃은 구체적으로, β3gnt2 유전자를 녹-아웃시킬 수 있는 재조합 벡터를 당단백질을 생성하는 세포주에 형질전환하는 것일 수 있다.Specifically, the recombination vector capable of knocking out the? 3gnt2 gene may be transformed into a cell line producing a glycoprotein.

상기 β3gnt2 유전자를 녹-아웃시킬 수 있는 재조합 벡터는 구체적으로, 서열번호 10 내지 13으로 구성된 군으로부터 선택되는 어느 하나의 가이드 RNA(guide RNA; gRNA)를 암호화하는 염기서열 및 서열번호 14로 기재되는 염기서열로 구성되는 Cas9(CRISPR associated protein 9) 유전자를 포함하는 것일 수 있고, 상기 재조합 벡터는 Cas9 유전자와 형광단백질을 코딩하는 유전자가 결합되어 있는 구조를 포함하는 것일 수 있다.The recombinant vector capable of knocking out the? 3gnt2 gene specifically comprises a nucleotide sequence encoding a guide RNA (gRNA) selected from the group consisting of SEQ ID NOS: 10 to 13, (CRISPR associated protein 9) gene consisting of a nucleotide sequence, and the recombinant vector may include a structure in which a Cas9 gene and a gene encoding a fluorescent protein are bound to each other.

구체적으로, 상기 β3gnt2 유전자를 녹-아웃시킬 수 있는 재조합 벡터는 서열번호 15 내지 18로 구성되는 군으로부터 선택되는 어느 하나의 염기서열을 포함할 수 있으나, 이에 한정되는 것은 아니다.Specifically, the recombinant vector capable of knocking out the? 3gnt2 gene may include any one selected from the group consisting of SEQ ID NOs: 15 to 18, but is not limited thereto.

상기 방법에 있어서, 상기 세포주는 포유동물 세포(mammalian cells), 효모 세포(yeast cells) 또는 곤충 세포(insect cells)를 사용할 수 있고, 상기 포유동물 세포는 중국 햄스터 난소 세포(chinese hamster ovary cells, CHO), HT-1080, 인간 림프아구(human lymphoblastoid), SP2/0(마우스 골수종), NS0(마우스 골수종), 베이비 햄스터 신장세포(baby hamster kidney cells, BHK), 인간 배아 신장세포(human embryonic kidney cells, HEK), PERC.6(인간 망막세포) 및 EC2-1H9 세포로 구성된 군으로부터 선택되는 어느 하나인 것일 수 있으며, 중국 햄스터 난소 세포(Chinese hamster ovary cells, CHO)인 것이 가장 바람직하나 이에 한정되지 않는다.In this method, the cell line may be mammalian cells, yeast cells or insect cells, and the mammalian cells may be chinese hamster ovary cells (CHO ), HT-1080, human lymphoblastoid, SP2 / 0 (mouse myeloma), NS0 (mouse myeloma), baby hamster kidney cells (BHK), human embryonic kidney cells , HEK), PERC.6 (human retinal cells), and EC2-1H9 cells, and most preferably Chinese hamster ovary cells (CHO), but not limited thereto Do not.

본 발명의 구체적인 실시예에서, 폴리락토사민 합성 관련 9종류의 유전자 후보군의 발현양상을 확인한 결과, β3gnt2 유전자가 가장 발현량이 높아 폴리락토사민 구조 합성에 가장 크게 관여할 타겟 유전자로 선정하였으며, β3gnt2의 발현을 저해할 타겟 siRNA 를 제작하였다(도 1 및 도 2 참조). 본 발명에서 제작한 siRNA에 의한 β3gnt2 유전자의 발현 억제와 그로 인한 폴리락토사민의 합성저해를 확인하기 위해 siRNA 처리된 CHO 세포에서 생산된 EPO를 대상으로 락토사미닐 반복(lactosaminyl repeat) 구조와 특이적으로 결합하는 렉틴(LEL)을 이용해 면역 블로팅을 수행하였고, 그 결과 siRNA-2 처리에 의해 β3gnt2 발현이 저해된 EPO는 약 70%의 시그널 감소를 나타내는 것을 확인하였다(도 3 참조). In a specific example of the present invention, expression patterns of nine candidate genes related to polylactosamine synthesis were examined. As a result, β3gnt2 gene was selected as a target gene most likely to be involved in the synthesis of polylactosamine structure due to its highest expression amount, and β3gnt2 A target siRNA to inhibit expression was prepared (see FIGS. 1 and 2). In order to confirm the suppression of β3gnt2 gene expression and inhibition of polylactosamine synthesis by siRNA produced by the present invention, EPO produced in siRNA-treated CHO cells was tested for lactosaminyl repeat structure and specific (LEL). As a result, it was confirmed that EPO in which β3gnt2 expression was inhibited by siRNA-2 treatment showed about 70% signal reduction (see FIG. 3).

또한, 본 발명자들은 폴리락토사민 억제에 의한 당쇄 구조의 정량적 변화를 확인하였고, 그 결과 총 N-글리칸에서 폴리락토사민이 차지하는 비율이 기존의 약 19%에서 2% 가량으로 현저히 감소했음을 확인하였으며(도 4a), 폴리락토사민 구조가 줄어든 것을 확인할 수 있었다(도 5 및 도 6). 또한, 삼중(tri-) 및 사중 안테나(tetra-antennary) N-글리칸의 비율이 증가함을 확인하였다(도 4b 참조). In addition, the present inventors confirmed the quantitative change of the sugar chain structure by the inhibition of polylactosamine, and as a result, it was confirmed that the proportion of polylactosamine in total N-glycan was significantly reduced from about 19% to 2% (Fig. 4A), confirming that the polylactosamine structure was reduced (Figs. 5 and 6). In addition, it was confirmed that the ratio of tri- and tetra-antennary N-glycans was increased (see FIG. 4B).

또한, 본 발명자들은 CRISPR/Cas9 시스템을 통한 β3gnt2 유전자 녹아웃 재조합 벡터를 제조하였고, 상기 재조합 벡터를 형질전환하여 녹아웃 효율을 확인하기 위해 T7E1 어세이를 수행한 결과 WT DNA에 비해 삽입된 세포의 DNA는 미스매치된 DNA 영역이 T7E1에 의해 잘려서 멀티 밴드(multi band)를 보이는 것을 확인하였으며(도 7b 참조), 유동세포계측법 및 생거-시퀀싱을 통해 녹아웃된 서열을 확인하였다(도 8 참조). 또한, β3gnt2 유전자가 녹아웃된 클론(클론 1: 15007-9 / 클론 2: 15402-2 / 클론 3: 15402-12 / 클론 4: 15402-16)으로부터 분리된 EPO는 모두 LEL와의 반응이 나타나지 않았으며(도 9a 참조), 총 N-글리칸에서 폴리락토사민이 차지하는 비율이 기존의 약 15%에서 2% 가량으로 현저히 감소했음을 확인하였다(도 9b 참조). 또한, 폴리락토사민이 감소함과 동시에 부가적으로 삼중(Tri-antennary) 및 사중 안테나(Tetra-antennary) N-글리칸의 비율이 증가함을 확인하였다(도 9c 참조). In addition, the present inventors prepared a β3gnt2 gene knockout recombinant vector through the CRISPR / Cas9 system. In order to confirm the knockout efficiency by transforming the recombinant vector, the T7E1 assay was performed. As a result, The mismatched DNA region was cut by T7E1 to show multi-band (see FIG. 7B), and the knocked-out sequence was confirmed by flow cytometry and ginger-sequencing (see FIG. 8). In addition, EPO isolated from the knockout clone of β3gnt2 gene (clone 1: 15007-9 / clone 2: 15402-2 / clone 3: 15402-12 / clone 4: 15402-16) did not show any reaction with LEL (See FIG. 9A), it was confirmed that the proportion of polylactosamine in the total N-glycan was significantly reduced from about 15% to about 2% (see FIG. 9B). In addition, it was confirmed that the ratio of tri-antennary and tetra-antennary N-glycans was increased while polylactosamine was decreased (see FIG. 9C).

따라서, 본 발명은 폴리락토사민의 생합성에 관여하는 β3gnt2 유전자의 발현을 억제(녹다운)하거나 β3gnt2 유전자를 녹아웃시킨 세포주로부터 생산된 재조합 인간 유래 에리스로포이에틴에서 폴리락토사민의 감소를 확인, 그에 따른 N-글리칸의 삼중 및/또는 사중 안테나 구조 증가를 확인함으로써 당단백질의 반감기 증가 및 당단백질 효능에 긍정적인 역할이 가능함을 확인한 바, 본 발명의 방법을 통해 반감기를 증가시킨 재조합 당단백질의 제조가 가능함을 확인하였다. Accordingly, the present invention provides a method for confirming the reduction of polylactosamine in recombinant human erythropoietin produced from a cell line in which expression of β3gnt2 gene involved in biosynthesis of polylactosamine is inhibited (knocked down) or β3gnt2 gene is knocked out, It is possible to positively increase the half-life of glycoprotein and the glycoprotein efficacy by confirming the increase of the triplet and / or quadrupole antenna structure of the cell. As a result, it is possible to produce a recombinant glycoprotein having an increased half-life through the method of the present invention Respectively.

또한, 본 발명은 상기 방법으로 제조된 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주를 제공한다. In addition, the present invention provides a recombinant cell line producing the recombinant glycoprotein produced by the above method and having an increased half-life.

또한, 본 발명은 In addition,

1) 상기 재조합 세포주를 배양하는 단계; 및1) culturing the recombinant cell line; And

2) 상기 단계 1)의 배양액에서 재조합 당단백질을 분리하는 단계를 포함하는, 반감기가 증가된 재조합 당단백질의 제조방법을 제공한다.2) separating the recombinant glycoprotein from the culture medium of step 1).

상기 당단백질은 에리스로포이에틴, 트롬보포이에틴, 알파-안티트립신, 콜린에스테라제, 융모성 고나도트로핀, CTLA4Ig, Factor Ⅷ, 감마-글루타밀트랜스퍼라아제, 과립구 콜로니 자극인자 및 황체형성호르몬으로 구성된 군으로부터 선택되는 어느 하나일 수 있고, 구체적으로는 에리스로포이에틴일 수 있으나, 이에 한정되지 않는다. The glycoprotein may be selected from the group consisting of erythropoietin, thrombopoietin, alpha- antitrypsin, choline esterase, chorionic gonadotropin, CTLA4Ig, Factor VIII, gamma-glutamyltransferase, granulocyte colony stimulating factor and luteinizing hormone And may be, but is not limited to, erythropoietin.

또한, 본 발명은 상기 방법으로 분리된, 반감기가 증가된 재조합 당단백질을 제공한다.In addition, the present invention provides recombinant glycoproteins with increased half-life, separated by the above method.

상기 방법으로 분리된 반감기가 증가된 재조합 당단백질은 N-글리칸(glycan)의 삼중(Tri-) 및/또는 사중-안테나(Tetra-antennary) 구조가 증가한 것을 특징으로 한다.The recombinant glycoprotein having an increased half-life separated by the above method is characterized by an increased tri- and / or tetra-antennary structure of N-glycan.

아울러, 본 발명은 서열번호 10 내지 13으로 구성된 군으로부터 선택되는 어느 하나의 가이드 RNA(guide RNA; gRNA)를 암호화하는 염기서열; 및 서열번호 14로 기재되는 염기서열로 구성되는 Cas9(CRISPR associated protein 9) 유전자를 포함하는, 재조합 벡터를 제공한다.In addition, the present invention provides a nucleic acid encoding a nucleotide sequence encoding a guide RNA (gRNA) selected from the group consisting of SEQ ID NOS: 10 to 13; And a Cas9 (CRISPR associated protein 9) gene consisting of the nucleotide sequence shown in SEQ ID NO: 14.

상기 재조합 벡터는 Cas9 유전자와 형광단백질을 코딩하는 유전자가 결합되어 있는 구조를 포함하는 것일 수 있으며, 구체적으로 상기 재조합 벡터는 서열번호 15 내지 18로 구성되는 군으로부터 선택되는 어느 하나의 염기서열을 포함하는 것일 수 있으나, 이에 한정되는 것은 아니다.The recombinant vector may include a structure in which a Cas9 gene and a gene encoding a fluorescent protein are bound to each other. Specifically, the recombinant vector may include any one of the nucleotide sequences selected from the group consisting of SEQ ID NOS: 15 to 18 , But is not limited thereto.

따라서, 본 발명은 폴리락토사민의 생합성에 관여하는 β3gnt2 유전자의 발현을 억제(녹다운)하거나 β3gnt2 유전자를 녹아웃시킨 세포주로부터 생산된 재조합 인간 유래 에리스로포이에틴에서 폴리락토사민의 감소를 확인, 그에 따른 N-글리칸의 삼중 및/또는 사중 안테나 구조 증가를 확인함으로써 당단백질의 반감기 증가 및 당단백질 효능에 긍정적인 역할이 가능함을 확인한 바, 본 발명의 방법을 통해 반감기를 증가시킨 재조합 당단백질의 제조가 가능함을 확인하였다.Accordingly, the present invention provides a method for confirming the reduction of polylactosamine in recombinant human erythropoietin produced from a cell line in which expression of β3gnt2 gene involved in biosynthesis of polylactosamine is inhibited (knocked down) or β3gnt2 gene is knocked out, It is possible to positively increase the half-life of glycoprotein and the glycoprotein efficacy by confirming the increase of the triplet and / or quadrupole antenna structure of the cell. As a result, it is possible to produce a recombinant glycoprotein having an increased half-life through the method of the present invention Respectively.

이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to examples.

단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 한정되는 것은 아니다.It should be noted, however, that the following examples are illustrative of the present invention and that the present invention is not limited to the following examples.

폴리락토사민Polylactosamine (( PolylactosaminePolylactosamine ) 합성 유전자의 ) Of the synthetic gene siRNA의siRNA 제작 making

<1-1> <1-1> 폴리락토사민Polylactosamine 합성 관련 유전자의 확인  Identification of Synthetic Genes

폴리락토사민의 합성은 갈락토스(galactose)에 β1,3-GlcNAc을 결합시키는 9종류(β3gnt1∼9)의 유전자가 관여하는데, 조직마다 혹은 세포종류마다 특이적으로 관여하는 유전자가 동일하지 않다. 이에 따라 9종류의 유전자 후보군의 발현양상을 비교하기 위해 3종류(EC2-1H9, 1098-2, CGT II-4)의 CHO 세포에서 qPCR을 수행하였다.The synthesis of polylactosamine involves nine kinds of genes (β3gnt1 to 9) that bind β1,3-GlcNAc to galactose, but the genes specifically involved in each tissue or cell type are not the same. Thus, qPCR was performed in CHO cells of three kinds (EC2-1H9, 1098-2, CGT II-4) in order to compare the expression pattern of nine candidate genes.

그 결과, 도 1에 나타낸 바와 같이 β3gnt2 유전자가 가장 발현량이 높아 폴리락토사민 구조 합성에 가장 크게 관여할 타겟 유전자로 선정하고, β3gnt2의 발현을 저해할 타겟 siRNA 를 제작하였다.As a result, as shown in Fig. 1, the target gene most likely to be involved in the synthesis of the polylactosamine structure was selected as the β3gnt2 gene with the highest expression amount, and a target siRNA to inhibit the expression of β3gnt2 was prepared.

<1-2> β3gnt2 유전자의 siRNA 제작<1-2> Construction of siRNA of β3gnt2 gene

β3gnt2 유전자의 siRNA를 제작하기 위해 siRNA 서열을 디자인하고 합성하였다. siRNA sequences were designed and synthesized to construct siRNA of β3gnt2 gene.

도 2에 나타낸 바와 같이 코딩 영역 위치에서 햄스터 β3gnt2 mRNA (GenBank accession no. XM_003502146.2; 서열번호 1)를 억제하는 세 개의 영역(siRNA-499, siRNA-1101 및 siRNA-970)에서 siRNA 서열을 디자인 및 합성하였다. 상기 siRNA에 사용된 올리고뉴클레오티드는 표 1에 기재된 바와 같다. SiRNA sequences were designed from three regions (siRNA-499, siRNA-1101 and siRNA-970) inhibiting hamster β3gnt2 mRNA (GenBank accession no. XM_003502146.2; SEQ ID NO: 1) at the coding region position as shown in FIG. And synthesized. The oligonucleotides used in the siRNAs are as described in Table 1.

siRNA 이름siRNA name 올리고뉴클레오티드 이름Oligonucleotide name 올리고뉴클레오티드 서열 Oligonucleotide sequence cDNA 상 위치location on cDNA siRNA-1siRNA-1 S-siRNA (서열번호 2)S-siRNA (SEQ ID NO: 2) 5'-GAAGAAATGCGCAAAGAA-3'5'-GAAGAAATGCGCAAAGAA-3 ' 499499 A-siRNA (서열번호 3)(타겟서열)A-siRNA (SEQ ID NO: 3) (target sequence) 5'-TTCTTTGCGCATTTCTTC-3'5'-TTCTTTGCGCATTTCTTC-3 ' siRNA-2siRNA-2 S-siRNA (서열번호 4)S-siRNA (SEQ ID NO: 4) 5'-CTGGAATGTGCCTTCAGAA-3'5'-CTGGAATGTGCCTTCAGAA-3 ' 11011101 A-siRNA (서열번호 5)(타겟서열)A-siRNA (SEQ ID NO: 5) (target sequence) 5'-TTCTGAAGGCACATTCCAG-3'5'-TTCTGAAGGCACATTCCAG-3 ' siRNA-3siRNA-3 S-siRNA (서열번호 6)S-siRNA (SEQ ID NO: 6) 5'-CATCCCAGAAGTCTTCTAT-3'5'-CATCCCAGAAGTCTTCTAT-3 ' 970970 A-siRNA (서열번호 7)(타겟서열)A-siRNA (SEQ ID NO: 7) (target sequence) 5'-ATAGAAGACTTCTGGGATG-3'5'-ATAGAAGACTTCTGGGATG-3 '

β3gnt2β3gnt2 유전자  gene 넉다운Knockdown (knock-down) (knock-down) CHOCHO 세포주의 구축 Construction of cell lines

상기 실시예 <1-2>에서 제작한 β3gnt2 유전자의 siRNA를 이용하여 인간 EPO 생산 CHO 세포주에 형질감염하였다. The CHO cell line producing human EPO was transfected with the siRNA of β3gnt2 gene prepared in Example <1-2>.

구체적으로, 재조합 인간 EPO 생산 CHO 세포주인 EC2-1H9는 Dr. Hyo Jeong Hong(Department of Systems Immunology, Kangwon National University, Chuncheon, Korea로부터 제공받았다. 세포는 10% dFBS (dialyzed fetal bovine serum; SAFC, US), 3.5 g/L glucose, 20 nM MTX (methotrexate; Sigma), 및 1% Ab-Am (Antibiotic-Antimycotic solution; Gibco)가 첨가된 MEM-α에서 37℃, 5% CO2의 환경에서 배양되었다.Specifically, the recombinant human EPO producing CHO cell line, EC2-1H9, Cells were treated with 10% dFBS (dialysed fetal bovine serum, SAFC, US), 3.5 g / L glucose, 20 nM MTX (methotrexate; Sigma) , And 1% Ab-Am (Antibiotic-Antimycotic solution; Gibco) at 37 ° C and 5% CO 2 .

상기 실시예 <1-2>에서 제작한 siRNA의 형질감염을 위해 EC2-1H9 세포는 제조업자의 프로토콜에 따라 Lipofectamine® RNAiMAX transfection reagent (Invitrogen, Carlsbad, CA, USA)를 이용하여 β3gnt2 특이적 또는 음성 대조군에 대한 siRNA(UGCG-specific siRNA) 10 μM로 형질감염하였다. 형질감염 24시간 후, 배지를 무혈청 배지(CHO-S-SFM II; Gibco)로 교환하고 37℃에서 5% CO2의 환경에서 추가적으로 3일간 배양하였다.For transfection of the siRNA prepared in Example <1-2>, EC2-1H9 cells were transfected with β3gnt2-specific or negative control group using Lipofectamine® RNAiMAX transfection reagent (Invitrogen, Carlsbad, CA, USA) Lt; / RTI &gt; (UGCG-specific siRNA). After 24 hours of transfection, the medium was exchanged with serum-free medium (CHO-S-SFM II; Gibco) and incubated for an additional 3 days in an environment of 5% CO 2 at 37 ° C.

<< 실험예Experimental Example 1>  1> β3gnt2β3gnt2 발현 저해(knock-down)를 통한  Through knock-down 폴리락토사민Polylactosamine 합성 저해 확인 Confirmation of inhibition of synthesis

β3gnt2 유전자의 siRNA 처리에 의한 β3gnt2 유전자의 발현 억제와 그로 인한 폴리락토사민의 합성저해를 확인하기 위해 siRNA 처리된 CHO 세포에서 생산된 EPO를 대상으로 락토사미닐 반복(lactosaminyl repeat) 구조와 특이적으로 결합하는 렉틴(Lycopersicon Esculentum Lectin, LEL)을 이용해 면역브로팅(immunoblotting)을 수행하였다.In order to confirm the inhibition of β3gnt2 gene expression by siRNA treatment of β3gnt2 gene and the inhibition of synthesis of polylactosamine by this treatment, EPO produced in CHO cell treated with siRNA was tested for lactosaminyl repeat structure and specific Immunoblotting was performed using the Lycopersicon Esculentum Lectin (LEL).

<1-1> <1-1> β3gnt2β3gnt2 유전자 발현 확인 Confirm gene expression

상기 <실시예 2>에서 구축한 재조합 CHO 세포의 총 RNA는 제조업자의 프로토콜에 따라 RNeasy® Mini (QIAGEN)를 이용하여 추출하였다. 1.0 ㎍의 RNA를 이용하여 AccuPower RT-PCR PreMix(Bioneer, Korea)을 이용하여 cDNA로의 역전사를 수행하였다. cDNA는 qPCR를 이용하여 β3gnt2의 mRNA 전사체를 확인하기 위한 템플레이트로 사용되었다. β3gnt2의 qPCR을 위해, 정방향(5'-CTG GCG ATT AAG TCC CTC ATT -3'; 서열번호 8) 및 역방향(5'-CTG GCG ATT AAG TCC CTC ATT -3'; 서열번호 9) 프라이머와 함께 iQTM SYBR® Green Supermix (Bio-Rad, Hercules, CA, USA)를 이용하였다.Total RNA of the recombinant CHO cells constructed in Example 2 was extracted using RNeasy 占 Mini (QIAGEN) according to the manufacturer's protocol. 1.0 μg of RNA was reverse-transcribed into cDNA using AccuPower RT-PCR PreMix (Bioneer, Korea). The cDNA was used as a template to identify mRNA transcripts of β3gnt2 using qPCR. (5'-CTG GCG ATT AAG TCC CTC ATT-3 '; SEQ ID NO: 8) and the reverse direction (5'-CTG GCG ATT AAG TCC CTC ATT-3'; SEQ ID NO: 9) primers for qPCR of? iQTM SYBR® Green Supermix (Bio-Rad, Hercules, Calif., USA) was used.

<1-2> 재조합 인간 유래 에리스로포이에틴(recombinant human erythropoietin; rhEPO)의 분리<1-2> Isolation of recombinant human erythropoietin (rhEPO) from recombinant human

재조합 인간 유래 에리스로포이에틴(rhEPO)을 분리하기 위해, rhEPO를 포함하고 있는 배양 상등액을 취합하고, 0.45 μm-pore-size 멤브레인을 이용해 통과시켰다. 통과시킨 배양 배지는 농축하여 ultrafiltration(AmiconUltra; Millipore, Bedford, MA)을 통해 PBS 버퍼 교환하였다. 그리고, rhEPO는 면역크로마토그래피 컬럼(immunoaffinity chromatography column, MAiiA, Uppsala, Sweden)를 이용해 정제하였다. 샘플을 로딩한 후 PBS로 세척한 뒤, 잔존하는 rhEPO는 0.1 M glycine/0.5 M NaCl, pH 2.8로 용출하고, 용출액은 즉시 1.0 M Tris/HCl, pH 9.0로 중화하였다. 정제된 rhEPO는 농축한 뒤 ultrafiltration(AmiconUltra; Millipore)를 이용하여 증류수로 투석하였다. rhEPO의 농도는 Quant-iT™ protein assay kit(Invitrogen)를 이용하여 측정하였다.To isolate recombinant human erythropoietin (rhEPO), the culture supernatant containing rhEPO was pooled and passed through a 0.45 μm-pore-size membrane. The passed culture medium was concentrated and exchanged with PBS buffer through ultrafiltration (AmiconUltra; Millipore, Bedford, Mass.). Then, rhEPO was purified using an immunoaffinity chromatography column (MAiiA, Uppsala, Sweden). After loading the sample and washing with PBS, the remaining rhEPO was eluted with 0.1 M glycine / 0.5 M NaCl, pH 2.8, and the eluate was immediately neutralized with 1.0 M Tris / HCl, pH 9.0. Purified rhEPO was concentrated and dialyzed with distilled water using ultrafiltration (AmiconUltra; Millipore). The concentration of rhEPO was determined using the Quant-iT ™ protein assay kit (Invitrogen).

<1-3> <1-3> 폴리락토사민의Of polylactosamine 발현 확인을 위한 면역  Immunity for confirmation of expression 블로팅Blotting

폴리락토사민의 발현 레벨을 확인하기 위해 렉틴 블랏(Lectin blot) 분석을 수행하였다. 구체적으로, Lycopersicon Esculentum Lectin(LEL)을 이용한 정제된 EPO 블로팅을 위해 상기 정제된 1 ㎍ EPO을 12.5% SDS PAGE에서 전기영동하고 PVDF 멤브레인(Millipore, Billerica, MA)로 옮겼으며, 바이오틴이 라벨된 LEL(Vector Laboratories Inc, Burlingame, CA, USA)로 블롯하였다. PVDF 멤브레인은 TBS-T[TBS(140 mM NaCl, 10 mM Tris-HCl, pH 8.0)/0.05% Tween 20]에서 5% BSA와 함께 1시간 동안 실온에서 블로킹(blocking)하였다. 블로킹 이후, 멤브레인은 TBS-T 내에서 1:500으로 희석된 바이오틴이 라벨된 렉틴과 함께 밤새 4℃에서 배양되었다. 이후 상기 멤브레인을 TBS-T로 3회 린스하고 1:5,000으로 희석된 ExtrAvidin-Peroxidase(2.0-2.5 mg/ml)와 함께 1시간 동안 실온에서 배양하여, 마지막으로 TBS-T로 5회 린스하여 Supersignal kit으로 처리하였다. Lectin blot analysis was performed to confirm expression levels of polylactosamine. Specifically, the purified 1 ㎍ EPO was electrophoresed on 12.5% SDS PAGE and transferred to PVDF membrane (Millipore, Billerica, MA) for purified EPO blotting using Lycopersicon Esculentum Lectin (LEL) LEL (Vector Laboratories Inc, Burlingame, Calif., USA). The PVDF membrane was blocked with 5% BSA in TBS-T [TBS (140 mM NaCl, 10 mM Tris-HCl, pH 8.0) /0.05% Tween 20] for 1 hour at room temperature. After blocking, the membrane was incubated overnight at 4 [deg.] C with biotin-labeled lectin diluted 1: 500 in TBS-T. The membrane was then rinsed three times with TBS-T and incubated with ExtraAvidin-Peroxidase (2.0-2.5 mg / ml) diluted 1: 5,000 for 1 hour at room temperature. Finally, the membrane was rinsed 5 times with TBS- kit.

항-EPO 항체를 이용한 리블롯팅(Reblotting)을 위해 다음과 같은 실험을 수행하였다. 구체적으로, EPO의 개수 제어를 위해 렉틴 블롯 이후 같은 블롯은 항-EPO 항체를 이용하여 리블롯팅을 실시하였다. 즉, 멤브레인은 스트립핑 버퍼(stripping buffer)(CANDOR Bioscience GmbH, Wangen imallgau, Germany)와 함께 30분간 실온에서 배양하였으며 TBS-T로 5회 세척하였다. 상기 멤브레인은 5% BSA와 함께 1시간 동안 실온에서 블록하였고 TBS-T 에서 1:10,000로 희석한 마우스 항-EPO 항체(100 ug/ml, Santa Cruz, CA)와 함께 밤새 배양하였다. 배양 후, 상기 멤브레인은 TBS-T로 5회 세척하였으며, Supersignal kit을 이용하여 처리되었다. 블로팅 지수는 렉틴 블롯에서 밴드 강도로써 계산되었으며 항-EPO 항체를 이용하여 웨스턴 블롯에서 리블롯 밴드 강도에 의해 나뉘었다. The following experiment was conducted for re-blotting using anti-EPO antibody. Specifically, for the control of the number of EPO, the same blot after lectin blotting was subjected to levotating using an anti-EPO antibody. Namely, the membrane was incubated with a stripping buffer (CANDOR Bioscience GmbH, Wangen imallgau, Germany) for 30 minutes at room temperature and washed five times with TBS-T. The membrane was incubated with 5% BSA in the presence of mouse anti-EPO antibody (100 ug / ml, Santa Cruz, Calif.) Diluted 1: 10,000 in TBS-T at room temperature for 1 hour. After incubation, the membranes were washed 5 times with TBS-T and treated with Supersignal kit. The blotting exponent was calculated as the band intensity in the lectin blot and divided by the levodrobite intensity in the Western blot using anti-EPO antibody.

그 결과, 도 3에 나타낸 바와 같이 siRNA-1 처리보다 siRNA-2 및 siRNA-3에 의한 β3gnt2 발현 저해 효과가 큰 것을 확인하였으며(도 3a 및 도 3b), siRNA-2 처리에 의해 β3gnt2 발현이 저해된 EPO는 blotting 결과 약 70%의 시그널 감소를 나타내는 것을 확인하였다(도 3c 및 도 3d). As a result, as shown in FIG. 3, it was confirmed that siRNA-2 and siRNA-3 inhibited the expression of β3gnt2 more effectively than siRNA-1 treatment (FIGS. 3a and 3b) and inhibited β3gnt2 expression by siRNA- EPO showed a signal reduction of about 70% as a result of blotting (FIG. 3C and FIG. 3D).

<< 실험예Experimental Example 2>  2> β3gnt2β3gnt2 발현 저해(knock-down)를 통한  Through knock-down rhEPO의rhEPO 안테나( antenna( antennaryantennary ) 구조 증가 확인) Confirmation of structure increase

β3gnt2 유전자의 siRNA를 통한 폴리락토사민 억제에 의한 당쇄 구조의 정량적 변화를 확인하기 위해 LC/MS 및 MALDI를 이용한 N-글리칸 질량분석을 수행하였다.N-glycan mass spectrometry using LC / MS and MALDI was performed to confirm quantitative changes in sugar chain structure due to inhibition of polylactosamine via siRNA of β3gnt2 gene.

구체적으로, 정제된 rhEPO는 100 mM 중탄산 암모늄(ammonium bicarbonate) 및 5 mM 디티오트레이톨(dithiothreitol)의 수용액에서 급속 열 순환(25-100℃)에 의해 변성되었다. 냉각시킨 후, 2.0 ul(또는 1000 U)의 펩티드 N-글리코시다아제(glycosidase) F를 첨가한 후, 혼합하여 16시간 동안 37℃ 워터 베이스에서 배양하였다. rhEPO 분해물은 카트리지에 로딩해 두고 순수한 물로 염 및 다른 버퍼 물질을 제거하기 위해 씻어 내었다. N-글리칸은 40% 아세토니트릴(acetonitrile)/0.05% 트리플루오로 아세트산(trifluoroacetic acid)의 첨가에 의해 물(산성 분획물; acidic fraction)에서 용출되었다. 샘플은 진공 하에 건조시켰다. rhEPO N-글리칸 분획은 물에 재용해시키고, 1.0 ul(rhEPO 1ug에 해당)는 스테인리스 강 표적 플레이트에 스폿팅하였다. 중성 글리칸은 양이온 모드([M+Na]+ 또는 [M+H]+)에서 분석된 반면, 산성 글리칸은 음이온 모드([M-H]-)에서 분석되었다. 각각의 획득한 스펙트럼은 현장에서 3개의 임의의 위치(총 2400개의 레이저 샷)에서 800 레이저 샷으로부터 결합된 신호를 나타내었다. 질량 스펙트럼은 m/z 2000-4500의 범위에 걸쳐 기록되었다. 말토올리고당 래더(maltooligosaccharide ladder)는 외부 질량 교정에 사용하였다. MS 피크는 5.0의 신호 대 잡음비로 필터링하고, 화합물 질량 및 강도 목록을 얻기 위해 디콘볼루션을 수행하였다. N- 글리칸 분획을 합치고 2.0 μL(800 ng EPO에 해당)의 양을 자동 시료 주입기로 다공성 흑연 탄소 나노-LC 칩(Agilent)에 주입하였다. 급속 글리칸 용출 구배를 (A) 3.0% 아세토니트릴/0.1% 포름산 수용액 및 (B) 90.0% 아세토니트릴/0.1% 포름산 수용액을 사용하여, 20분 동안 6%에서 100% B로 상승하도록 분석용 칼럼에 0.3 μL/분으로 적용하였다. 남아있는 비-글리칸 화합물을 100% B로 씻어낸 다음 재평형시켰다. MS 스펙트럼은 스펙트럼 당 1.5초의 획득 시간으로 m/z 500-2000의 질량 범위에서 양이온 모드로 획득되었다.Specifically, purified rhEPO was denatured by rapid thermal cycling (25-100 ° C) in aqueous solutions of 100 mM ammonium bicarbonate and 5 mM dithiothreitol. After cooling, 2.0 ul (or 1000 U) of peptide N-glycosidase F was added, followed by mixing and incubation for 16 hours in a 37 ° C water base. The rhEPO lysate was loaded onto the cartridge and washed to remove salts and other buffer material with pure water. N-glycans were eluted from the water (acidic fraction) by the addition of 40% acetonitrile / 0.05% trifluoroacetic acid. The sample was dried under vacuum. The rhEPO N-glycan fraction was redissolved in water and 1.0 ul (corresponding to 1 ug of rhEPO) was spotted onto a stainless steel target plate. Neutral glycans were analyzed in cationic mode ([M + Na] + or [M + H] + ), while acid glycans were analyzed in anion mode ([M - H] - ). Each acquired spectra showed a combined signal from 800 laser shots at three arbitrary locations in the field (2400 total laser shots). Mass spectra were recorded over the range of m / z 2000-4500. Maltooligosaccharide ladder was used for external mass calibration. The MS peak was filtered with a signal to noise ratio of 5.0 and deconvolution was performed to obtain a list of compound mass and strength. N-glycan fractions were combined and the amount of 2.0 μL (corresponding to 800 ng EPO) was injected into a porous graphite carbon nano-LC chip (Agilent) with an automatic sample injector. The rapid glycan elution gradient was analyzed using an analytical column (HPLC) to ascend from 6% to 100% B for 20 minutes using (A) aqueous solution of 3.0% acetonitrile / 0.1% formic acid and (B) 90.0% acetonitrile / 0.0 &gt; uL / min. &Lt; / RTI &gt; The remaining non-glycan compounds were washed out with 100% B and then re-equilibrated. The MS spectrum was acquired in cationic mode at a mass range of m / z 500-2000 with an acquisition time of 1.5 seconds per spectrum.

그 결과, 도 4 내지 도 6에 나타낸 바와 같이 총 N-글리칸에서 폴리락토사민이 차지하는 비율이 기존의 약 19%에서 2% 가량으로 현저히 감소했음을 확인하였으며(도 4a), MALDI-TOF MS 및 LC/MS 결과 폴리락토사민 구조가 줄어든 것을 확인할 수 있었다(도 5 및 도 6). As a result, as shown in Figs. 4 to 6, it was confirmed that the proportion of polylactosamine in the total N-glycan was significantly reduced from about 19% to about 2% (Fig. 4A), and MALDI-TOF MS and LC / MS showed that the polylactosamine structure was reduced (Figs. 5 and 6).

또한, 폴리락토사민이 감소함과 동시에 부가적으로 삼중(tri-) 및 사중 안테나(tetra-antennary) N-글리칸의 비율이 증가함을 확인하였다(도 4b). 이는 폴리락토사민 합성에 사용될 구성성분(component)들이 안테나 분기(Antenna branching)에 사용되었기 때문으로 보인다. 문헌에 의하면, 이중 안테나(Bi-antennary) 당쇄구조를 갖는 EPO는 사중 안테나(Tetra-antennary) 당쇄 구조를 갖는 EPO에 비해 in-vivo 활성이 약 85% 감소하는 것으로 보고된 바 있다(Takeuchi et al, PNAS, 1989). 따라서, 폴리락토사민 감소와 그에 따른 사중 안테나 구조의 증가는 당단백질의 반감기 증가와 당단백질 효능에 긍정적인 역할을 할 수 있는 결과라 할 수 있다.In addition, it was confirmed that the proportion of tri- and tetra-antennary N-glycans was increased while polylactosamine was decreased (Fig. 4B). This seems to be because the components used for polylactosamine synthesis were used for antenna branching. According to the literature, EPO having a bi-antennary sugar chain structure has been reported to have an in-vivo activity reduction of about 85% as compared to EPO having a tetra-antennary sugar chain structure (Takeuchi et al , PNAS, 1989). Therefore, the reduction of polylactosamine and consequently the increase of quadrupole antenna structure can be a positive effect on the increase of half-life of glycoprotein and glycoprotein efficacy.

β3gnt2β3gnt2 유전자  gene 넉아웃Knockout (knock-out) (knock-out) CHOCHO 세포주의 구축 Construction of cell lines

<3-1> 재조합 인간 EPO를 생산하는 <3-1> Production of recombinant human EPO CHOCHO 세포의 준비 Cell preparation

재조합 인간 EPO를 생산하는 CHO 세포인 EC2-1H9 세포는 Dr. Hyo Jeong Hong (Antibody Engineering Research Unit, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon, Korea)로부터 제공받았다. 세포는 10% (v/v) dFBS (Gibco), 3.5 g/L glucose, 20 nM MTX (methotrexate; Sigma), 및 1% (v/v) Ab-Am (antibiotic-antimycotic solution; Gibco)로 보충된 MEM-α(Gibco)에서 37℃, 5%의 CO2를 포함하는 가습 환경에서 유지되었다. EC2-1H9 cells, which are recombinant human EPO producing CHO cells, Hyo Jeong Hong (Antibody Engineering Research Unit, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon, Korea). Cells were supplemented with 10% (v / v) dFBS (Gibco), 3.5 g / L glucose, 20 nM MTX (methotrexate; Sigma), and 1% (v / v) Ab-Am (antibiotic-antimycotic solution; Gibco) Gt; 37 C &lt; / RTI &gt; in 5% CO 2 in MEM-a (Gibco).

<3-2> <3-2> CRISPRCRISPR // Cas9Cas9 시스템을 통한  Through the system β3gnt2β3gnt2 유전자 녹아웃 재조합 벡터의 제조 및 형질전환 Production and Transformation of a Gene Knockout Recombinant Vector

β3gnt2 유전자를 녹아웃시키기 위한 재조합 벡터를 제조하기 위해 사용한 gRNA(guide RNA)를 암호화하는 DNA 서열은 CHO-K1 게놈에 특화된 웹 기반 CRISPR 디자인 툴인 CPRISPy로부터 얻었다. 이와 같은 gRNA는 차이니스 햄스터의 β3gnt2 유전자를 특이적으로 인식하여 각각이 β3gnt2 유전자의 DNA 가닥을 녹아웃하도록 고안된 gRNA 서열을 암호화하는 DNA 서열(합성 올리고뉴클레오티드)이다. 이는 하기 표 1의 서열번호 10 내지 13으로 나타내었다The DNA sequence encoding the gRNA (guide RNA) used to produce the recombinant vector to knock out the β3gnt2 gene was obtained from CPRISPy, a web-based CRISPR design tool specific to the CHO-K1 genome. Such a gRNA is a DNA sequence (synthetic oligonucleotide) that specifically recognizes the β3gnt2 gene of Chais hamsters and each encodes a gRNA sequence designed to knock out the DNA strand of the β3gnt2 gene. This is shown in SEQ ID NOS: 10 to 13 in Table 1 below

유전자 내 위치Location in the gene 염기서열Base sequence 서열번호SEQ ID NO: gRNA-1gRNA-1 1500715007 TGTTCCAGTACGCCCGGGAA (-)TGTTCCAGTACGCCCGGGAA (-) 서열번호 10SEQ ID NO: 10 gRNA-2gRNA-2 1518115181 AGTCTTTAAATCTGTCCGGC (-)AGTCTTTAAATCTGTCCGGC (-) 서열번호 11SEQ ID NO: 11 gRNA-3gRNA-3 1538515385 GTAGTGAGAGTCTTCTTGTT (+)GTAGTGAGAGTCTTCTTGTT (+) 서열번호 12SEQ ID NO: 12 gRNA-4gRNA-4 1540215402 GTTGGGCAAGACGCCCCCCG (+)GTTGGGCAAGACGCCCCCCG (+) 서열번호 13SEQ ID NO: 13

gRNA 서열을 암호화하는 DNA 서열(gRNA-1, gRNA-2, gRNA-3, gRNA-4)은, gRNA를 발현하는 U6 프로모터 및 발현된 gRNA를 인식하는 GFP가 태그된 Cas9 효소를 포함하는, pCas-Guide-EF1a 벡터(Origene, Rockville, Maryland)로 삽입되었다. 상기 벡터는 생체 내 전사시에 서열번호 10 내지 13의 염기서열로 표시되는 DNA로부터 gRNA를, 서열번호 14의 염기서열로 표시되는 Cas9 DNA 서열로부터 Cas9 mRNA를 생성하는 주형으로 사용되었다. 이때 Cas9 유전자는 링커인 2A 펩타이드를 통해 GFP를 암호화하는 유전자와 연결되어 있어, 한 번에 Cas9 단백질과 GFP 단백질이 발현될 수 있다. 상기 과정을 통해 제작한 재조합 벡터의 개열 지도는 도 7에 나타내었으며, 재조합 벡터의 전체 염기서열은 서열번호 15 내지 18로 나타내었다.The DNA sequences (gRNA-1, gRNA-2, gRNA-3, gRNA-4) encoding the gRNA sequence were amplified by PCR using the pCas -Guide-EF1a vector (Origene, Rockville, Maryland). The vector was used as a template to generate gRNA from the DNA represented by the nucleotide sequence of SEQ ID NOS: 10 to 13 and Cas9 mRNA from the Cas9 DNA sequence represented by the nucleotide sequence of SEQ ID NO: 14 at the time of in vivo transcription. At this time, the Cas9 gene is linked to a gene encoding GFP through the linker 2A peptide, so that Cas9 protein and GFP protein can be expressed at once. The cleavage map of the recombinant vector prepared in the above procedure is shown in FIG. 7, and the entire nucleotide sequence of the recombinant vector is shown in SEQ ID NOs: 15 to 18.

상기 제조된 pCas-B3gnt2-EF1a 벡터는 Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA)를 이용하여 상기 실시예 <3-1>의 EC2-1H9 세포로 형질전환되었다. The pCas-B3gnt2-EF1a vector prepared above was transformed into EC2-1H9 cells of Example <3-1> using Lipofectamine ™ 2000 (Invitrogen, Carlsbad, Calif.).

<< 실험예Experimental Example 3> β3gnt23> β3gnt2 유전자 녹-아웃(knock-out) 결과 Gene knock-out results

<3-1> <3-1> T7E1T7E1 어세이Assay (assay)(assay)

CRISPR/Cas9 시스템에 의해 지놈의 특정부위가 삽입(edition)되었을 때 해당 지놈 영역에 비상동성 말단 접합(Non Homologous end-joining; NHEJ)이 발생한다. 이런 형태의 DNA를 변성(denaturation)한 뒤 온도를 낮춰서 혼성화(hybridization)시키면 삽입되지 않은 와일드 타입(WT)의 DNA와 삽입된 클론의 DNA가 미스매치(Mismatch) 형태로 결합하는 이질성 염기쌍(hetero duplex)이 생기며 T7E1 은 이러한 미스매치된 DNA 영역을 인지하여 자르게 된다. Non-homologous end-joining (NHEJ) occurs in the genome region when a specific region of the genome is inserted by the CRISPR / Cas9 system. When DNA of this type is denaturated and hybridization is performed at a low temperature, the DNA of the wild type (WT) that is not inserted and the DNA of the inserted clone are mixed with the heteroduplex (mismatch) ), And T7E1 recognizes these mismatched DNA regions and cuts them.

상기 실시예 <3-2>에서 CRISPR/Cas9 시스템을 통해 B3gnt2 유전자가 녹-아웃된 안정화된 세포주(stable cell line) 구축에 앞서 gRNA에 의한 유전자의 삽입/결실의 빈도(Indel, %)를 측정하는 T7E1 assay을 수행하였다.(Indel,%) of gene insertion / deletion by gRNA was measured prior to the construction of the stable cell line in which the B3gnt2 gene was knocked out through the CRISPR / Cas9 system in the above Example <3-2> Lt; / RTI &gt; assay was performed.

구체적으로, 형질전환된 세포에서 Genomic DNA를 추출하여 정량한 뒤 200 ng의 genomic DNA를 주형(template)으로 하여 PCR을 수행하였고, 사용된 프라이머쌍은 4종류의 gRNA의 인식부위를 모두 커버하는 범위(849 bp)로 제작하였다(정방향 : 5'- GCA TTG TGG ATC ACG TCA CCT ATA AAC -3'(서열번호 19)/역방향: 5'- CCA GAT ATG AGA AAT GAG TGT TGG ACG -3'(서열번호 20)). 2 ㎕의 PCR products를 1.5% Agarose gel을 이용해 전기영동하였고 제대로 된 product 사이즈를 확인한 후 키트(qiaquick pcr purification kit; Qiagen)를 이용해 정제하였다. 정제된 PCR product의 DNA 농도를 정량한 뒤 10X NEB buffer 2 ul + PCR product 200 ng + DDW를 최종 19 ㎕으로 맞추었고 서모사이클러(thermocycler)를 이용해 DNA를 변성(denaturation) 및 혼성화(hybridization)하여 어닐링된(Annealed) DNA 단편(fragment)에 T7 Endonuclease 1(T7E1) 1㎕를 첨가한 뒤 37℃에서 15분 반응시켰다. 이후, proteinase K를 이용해 T7E1을 불활성화시키고 다시 1.5% Agarose gel에서 전기영동하여 대조군과 비교하였으며, 불완전하게 매치된(Non-perfectly matched) DNA가 T7E1에 의해 잘려진 비율이 어느정도 되는지 확인하였다. 전체 밴드의 세기(intensity)(잘려나가지 않은 WT 위치의 밴드 + 잘려나간 단편들의 밴드) 및 잘려나간 단편들(특정위치를 절단하므로 두 위치에서 단편들의 밴드가 생겨남)의 밴드의 세기의 비율을 Indel(%, genome edition efficiency)로 계산하였다. Specifically, the genomic DNA was extracted from the transformed cells, quantified, and PCR was performed using 200 ng of the genomic DNA as a template. The primer pair used was a range covering all four recognition sites of the gRNA (SEQ ID NO: 19) / reverse direction: 5'-CCA GAT ATG AGA AAT GAG TGT TGG ACG-3 '(Sequence: SEQ ID NO: No. 20)). 2 μl of PCR products were electrophoresed using 1.5% agarose gel. After confirming proper product size, the product was purified using a qiaquick PCR purification kit (Qiagen). The DNA concentration of the purified PCR product was quantitated and 2 μl of 10 × NEB buffer + 200 ng of PCR product + DDW was added to the final 19 μl, followed by denaturation and hybridization of the DNA using a thermocycler To the annealed DNA fragment, 1 μl of T7 Endonuclease 1 (T7E1) was added, followed by reaction at 37 ° C for 15 minutes. Then, T7E1 was inactivated with proteinase K, and then electrophoresed on 1.5% agarose gel, and compared with the control, and it was confirmed how much the incompletely matched DNA was cleaved by T7E1. The ratio of the intensities of the bands of the whole band intensity (bands of uncut WT positions + cut-out fragments) and cut-out fragments (bands of fragments at two positions due to cutting a specific position) (%, genome edition efficiency).

그 결과, 도 7b에 나타낸 바와 같이 4종류의 gRNA를 이용한 녹-아웃 효율 확인 결과 T7E1에 의해 잘리지 않는 WT DNA에 비해 삽입된 세포의 DNA는 미스매치된 DNA 영역이 T7E1에 의해 잘려서 멀티 밴드(multi band)를 보이는 것을 확인하였다(도 7b). 즉, 4종류의 gRNA가 모두 녹-아웃 작동을 하였다는 것을 확인하였다.As a result, as shown in FIG. 7B, when the r-out efficiency using four kinds of gRNA was confirmed, compared with the WT DNA not truncated by T7E1, the DNA of the inserted cell was truncated by T7E1 and the multi- band (Fig. 7B). That is, it was confirmed that all of the four kinds of gRNAs performed the rust-out operation.

<3-2> <3-2> 생거Sanger -시퀀싱(- Sequencing sangersanger -sequencing)-sequencing)

상기 <실시예 3>에서 CRISPR/Cas9 시스템을 통해 β3gnt2 유전자가 녹아웃된 세포는 유동세포계측법(Flow cytometry (Beckman coulter Inc, Brea, CA))을 통해 성공적으로 형질전환된 클론을 3주간 선택하였다(도 8a). 선택된 클론(클론 1: gRNA-1의 9 / 클론 2: gRNA-4의 2 / 클론 3: gRNA-4의 12 / 클론 4: gRNA-4의 16)은 게놈 DNA에 기초한 PCR에 따른 생거-시퀀싱에 의해 확인되었다(도 8b).Cells in which the β3gnt2 gene was knocked out through the CRISPR / Cas9 system in Example 3 were selected for 3 weeks by flow cytometry (Beckman coulter Inc, Brea, Calif.), And successfully transformed clones for 3 weeks 8A). The selected clone (clone 1: gRNA-1 9 / clone 2: gRNA-4 2 / clone 3: gRNA-4 12 / clone 4: gRNA-4 16) (Fig. 8B).

<< 실험예Experimental Example 4>  4> β3gnt2β3gnt2 유전자 녹-아웃을 통한  Through gene knock-out 폴리락토사민Polylactosamine 합성 저해 및 안테나 구조 증가 확인 Synthesis inhibition and confirmation of increased antenna structure

<4-1> <4-1> 폴리락토사민Polylactosamine 합성 저해 확인 Confirmation of inhibition of synthesis

상기 β3gnt2 유전자가 녹-아웃 되었음이 확인된 EC2-1H9 세포 5.0x106는 10%(v/v) dFBS, 3.5 g/L glucose, 1% (v/v) Ab-Am solution, 및 20 nM MTX이 보충된 MEM-α를 포함하는 T175 배양 플라스크에 배양하였다. 재조합 인간 유래 에리스로포이에틴(rhEPO)을 포함하는 배양 배지를 SDS-PAGE에 사용되었고, 이어서 PVDF 멤브레인(Millipore Corp., Bedford, MA)으로 옮겼다. 5% BSA와 함께 TBS-T (140 mM NaCl, 10 mM Tris-HCl, with 0.05% Tween 20, pH 8.0)으로 실온에서 2시간 동안 블로킹 후, PVDF 멤브레인은 바이오틴이 라벨된 렉틴(Lycopersicon Esculentum Lectin; LEL)과 함께 4℃에서 16시간 동안 배양되었다. TBS-T를 이용하여 5분간 3회 세척한 후, 멤브레인은 1시간 동안 실온에서 ExtrAvidin-peroxidase (Sigma)와 함께 배양한 후 ECL 키트(Thermo Scientific; Rockford, IL)로 전개시켰다. EC2-1H9 cells in which the β3gnt2 gene was confirmed to have been knocked out had 5.0 × 10 6 cells of 10% (v / v) dFBS, 3.5 g / L glucose, 1% (v / v) Ab- Lt; RTI ID = 0.0 &gt; MEM-a. &Lt; / RTI &gt; Culture medium containing recombinant human erythropoietin (rhEPO) was used for SDS-PAGE and then transferred to PVDF membrane (Millipore Corp., Bedford, Mass.). After blocking for 2 hours at room temperature with TBS-T (140 mM NaCl, 10 mM Tris-HCl, with 0.05% Tween 20, pH 8.0) with 5% BSA, PVDF membranes were incubated with biotin labeled lectin (Lycopersicon Esculentum Lectin; LEL) at 4 &lt; 0 &gt; C for 16 hours. After washing three times for 5 minutes with TBS-T, the membranes were incubated with ExtrAvidin-peroxidase (Sigma) at room temperature for 1 hour and developed with ECL kit (Thermo Scientific; Rockford, Ill.).

리블로팅(reblotting)을 위해, 상기 멤브레인은 스트립핑 버퍼(stripping buffer)(Candor Bioscience GmbH, Weissensberg, Germany)를 이용하여 1시간 동안 실온에서 스트립핑 시켰다. PVDF 멤브레인은 TBS-T로 5분 동안 3회 세척한 후, 1:5000으로 희석된 RP 라벨된 항-마우스 IgG 항체(Santa Cruz)와 함께 실온에서 1시간 동안 배양되었다. 멤브레인은 ECL 용액(Thermo Scientific; Rockford, IL)으로 전개시켰다. For reblotting, the membrane was stripped at room temperature for 1 hour using a stripping buffer (Candor Bioscience GmbH, Weissensberg, Germany). The PVDF membrane was washed three times for 5 minutes with TBS-T and then incubated with RP-labeled anti-mouse IgG antibody (Santa Cruz) diluted 1: 5000 for 1 hour at room temperature. Membranes were developed with ECL solution (Thermo Scientific; Rockford, Ill.).

그 결과, 도 9a에 나타낸 바와 같이 β3gnt2 유전자가 녹아웃된 클론(클론 1: gRNA-1의 9 / 클론 2: gRNA-4의 2 / 클론 3: gRNA-4의 12 / 클론 4: gRNA-4의 16)으로부터 분리된 EPO는 모두 LEL와의 반응이 나타나지 않았다(도 9a).As a result, as shown in FIG. 9A, a clone in which β3gnt2 gene was knocked out (clone 1: 9 of gRNA-1 / clone 2: 2 of gRNA-4 / clone 3: 12 of gRNA- 16) did not show any reaction with LEL (Fig. 9A).

<4-2> 안테나 구조 증가 확인<4-2> Confirmation of increase of antenna structure

상기 β3gnt2 유전자가 녹-아웃 되었음이 확인된 EC2-1H9 세포 5.0x106는 10%(v/v) dFBS, 3.5 g/L glucose, 1% (v/v) Ab-Am solution, 및 20 nM MTX이 보충된 MEM-α를 포함하는 T175 배양 플라스크에 배양하였다. 배양 배지는 3일 안에 혈청이 없는(serum-free) 배지(CHO-S-SFM II; Gibco)로 교체하였다. 2일 후, 배양 배지를 수집하여 0.45 um 필터(Sartorius, Gottingen, Germany)로 필터한 후, 인산 완충 생리식염수(phosphate buffer saline (PBS, pH 7.4))로 4℃에서 밤새 투석하였다. rhEPO를 정제하기 위해, 배양 배지는 EPO 정제 젤(MAIIA Diagnostics, Uppsala, Sweden)을 이용하였다. 정제된 rhEPO는 4℃에서 밤새 증류수로 투석되었다. 농도는 Quant-iT™ protein assay kit(Invitrogen)를 이용하여 측정하였으며, 사용시까지 -80℃에 보관하였다.EC2-1H9 cells in which the β3gnt2 gene was confirmed to have been knocked out had 5.0 × 10 6 cells of 10% (v / v) dFBS, 3.5 g / L glucose, 1% (v / v) Ab- Lt; RTI ID = 0.0 &gt; MEM-a. &Lt; / RTI &gt; The culture medium was replaced with serum-free medium (CHO-S-SFM II; Gibco) within 3 days. After 2 days, the culture medium was collected and filtered with a 0.45 μm filter (Sartorius, Göttingen, Germany) and dialyzed overnight at 4 ° C. with phosphate buffer saline (PBS, pH 7.4). To purify rhEPO, the culture medium was EPO purified gel (MAIIA Diagnostics, Uppsala, Sweden). The purified rhEPO was dialyzed overnight at 4 ° C with distilled water. Concentrations were measured using the Quant-iT ™ protein assay kit (Invitrogen) and stored at -80 ° C until use.

구체적으로, 정제된 rhEPO는 100 mM 중탄산 암모늄(ammonium bicarbonate) 및 5 mM 디티오트레이톨(dithiothreitol)의 수용액에서 급속 열 순환(25-100℃)에 의해 변성되었다. 냉각시킨 후, 2.0 ul(또는 1000 U)의 펩티드 N-글리코시다아제(glycosidase) F를 첨가한 후, 혼합하여 16시간 동안 37℃ 워터 베이스에서 배양하였다. rhEPO 분해물은 카트리지에 로딩해 두고 순수한 물로 염 및 다른 버퍼 물질을 제거하기 위해 씻어 내었다. N-글리칸은 40% 아세토니트릴(acetonitrile)/0.05% 트리플루오로 아세트산(trifluoroacetic acid)의 첨가에 의해 물(산성 분획물; acidic fraction)에서 용출되었다. 샘플은 진공 하에 건조시켰다. rhEPO N-글리칸 분획은 물에 재용해시키고, 1.0 ul(rhEPO 1ug에 해당)는 스테인리스 강 표적 플레이트에 스폿팅하였다. 중성 글리칸은 양이온 모드([M+Na]+ 또는 [M+H]+)에서 분석된 반면, 산성 글리칸은 음이온 모드([M-H]-)에서 분석되었다. 각각의 획득한 스펙트럼은 현장에서 3개의 임의의 위치(총 2400개의 레이저 샷)에서 800 레이저 샷으로부터 결합된 신호를 나타내었다. 질량 스펙트럼은 m/z 2000-4500의 범위에 걸쳐 기록되었다. 말토올리고당 래더(maltooligosaccharide ladder)는 외부 질량 교정에 사용하였다. MS 피크는 5.0의 신호 대 잡음비로 필터링하고, 화합물 질량 및 강도 목록을 얻기 위해 디콘볼루션을 수행하였다. N- 글리칸 분획을 합치고 2.0 μL(800 ng EPO에 해당)의 양을 자동 시료 주입기로 다공성 흑연 탄소 나노-LC 칩(Agilent)에 주입하였다. 급속 글리칸 용출 구배를 (A) 3.0% 아세토니트릴/0.1% 포름산 수용액 및 (B) 90.0% 아세토니트릴/0.1% 포름산 수용액을 사용하여, 20분 동안 6%에서 100% B로 상승하도록 분석용 칼럼에 0.3 μL/분으로 적용하였다. 남아있는 비-글리칸 화합물을 100% B로 씻어낸 다음 재평형시켰다. MS 스펙트럼은 스펙트럼 당 1.5초의 획득 시간으로 m/z 500-2000의 질량 범위에서 양이온 모드로 획득되었다.Specifically, purified rhEPO was denatured by rapid thermal cycling (25-100 ° C) in aqueous solutions of 100 mM ammonium bicarbonate and 5 mM dithiothreitol. After cooling, 2.0 ul (or 1000 U) of peptide N-glycosidase F was added, followed by mixing and incubation for 16 hours in a 37 ° C water base. The rhEPO lysate was loaded onto the cartridge and washed to remove salts and other buffer material with pure water. N-glycans were eluted from the water (acidic fraction) by the addition of 40% acetonitrile / 0.05% trifluoroacetic acid. The sample was dried under vacuum. The rhEPO N-glycan fraction was redissolved in water and 1.0 ul (corresponding to 1 ug of rhEPO) was spotted onto a stainless steel target plate. Neutral glycans were analyzed in cationic mode ([M + Na] + or [M + H] + ), while acid glycans were analyzed in anion mode ([M - H] - ). Each acquired spectra showed a combined signal from 800 laser shots at three arbitrary locations in the field (2400 total laser shots). Mass spectra were recorded over the range of m / z 2000-4500. Maltooligosaccharide ladder was used for external mass calibration. The MS peak was filtered with a signal to noise ratio of 5.0 and deconvolution was performed to obtain a list of compound mass and strength. N-glycan fractions were combined and the amount of 2.0 μL (corresponding to 800 ng EPO) was injected into a porous graphitic carbon nano-LC chip (Agilent) using an autosampler. The rapid glycan elution gradient was analyzed using an analytical column (HPLC) to ascend from 6% to 100% B for 20 minutes using (A) aqueous solution of 3.0% acetonitrile / 0.1% formic acid and (B) 90.0% acetonitrile / 0.0 &gt; uL / min. &Lt; / RTI &gt; The remaining non-glycan compounds were washed out with 100% B and then re-equilibrated. The MS spectrum was acquired in cationic mode at a mass range of m / z 500-2000 with an acquisition time of 1.5 seconds per spectrum.

그 결과, 도 9b에 나타낸 바와 같이 총 N-글리칸에서 폴리락토사민이 차지하는 비율이 기존의 약 15%에서 2% 가량으로 현저히 감소했음을 확인하였다(도 9b).As a result, it was confirmed that the proportion of polylactosamine in the total N-glycan was significantly reduced from about 15% to about 2% as shown in Fig. 9B (Fig. 9B).

또한, 폴리락토사민이 감소함과 동시에 부가적으로 사중 안테나(tetra-antennary) N-글리칸의 비율이 증가함을 확인하였다(도 9c). In addition, it was confirmed that the proportion of tetra-antennary N-glycans was increased while polylactosamine was decreased (FIG. 9C).

이는 폴리락토사민 합성에 사용될 구성성분(component)들이 안테나 분기(Antenna branching)에 사용되었기 때문으로 보인다. 문헌에 의하면, 이중 안테나(Bi-antennary) 당쇄구조를 갖는 EPO는 사중 안테나(Tetra-antennary) 당쇄 구조를 갖는 EPO에 비해 in-vivo 활성이 약 85% 감소하는 것으로 보고된 바 있다(Takeuchi et al, PNAS, 1989). 따라서, 폴리락토사민 감소와 그에 따른 사중 안테나 구조의 증가는 당단백질의 반감기 증가와 당단백질 효능에 긍정적인 역할을 할 수 있는 결과라 할 수 있다.This seems to be because the components used for polylactosamine synthesis were used for antenna branching. According to the literature, EPO having a bi-antennary sugar chain structure has been reported to have an in-vivo activity reduction of about 85% as compared to EPO having a tetra-antennary sugar chain structure (Takeuchi et al , PNAS, 1989). Therefore, the reduction of polylactosamine and consequently the increase of quadrupole antenna structure can be a positive effect on the increase of half-life of glycoprotein and glycoprotein efficacy.

<110> Korea Advanced Institute of Science and Technology <120> Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine <130> 2017P-07-017 <150> KR 10-2016-0100674 <151> 2016-08-08 <160> 20 <170> KoPatentIn <210> 1 <211> 2670 <212> RNA <213> Cricetulus griseus <400> 1 tcagatttat gtctgataat ccacactgag atgtcccacc cagagctgtt tgggcacctt 60 cgtagtatga gctagcttat aaaagatatg agaaatgagt gttggacgtc gaagaataaa 120 gttgttgggt atcctgatga tggcaaatgt cttcatttat ttgattgtgg aagtctccaa 180 aaatagtagc caagaaaaaa atggaaaggg gggagtaata atacccaaag aaaagttctg 240 gaagatattc agcccttccc gggcgtactg gaacagagag caagagaaac tgaacaagtg 300 gtacaatccc attctgaaca ggctggccaa ccagacaggg gatttgtatt cgtctccaaa 360 tataagtcat ctgggctatt gtgaacctga cccaagggtc atgacagctg tgacagattt 420 taataacctg ccggacagat ttaaagactt cctcttgtat ttgagatgcc gaaattactc 480 actgcttata gatcaaccga agaaatgcgc aaagaaaccc ttcttactgc tggcgattaa 540 gtccctcatt ccacattttg ccagaaggca agcaattcgg gaatcttggg gcagagaaac 600 caatgtgggg aaccagacag tagtgagagt cttcttgttg ggcaagacgc cccccgagga 660 caaccaccct gacctttcag acatgctgaa gtttgagagt gagaggcacc aggacattct 720 catgtggaac tatagagaca ctttcttcaa cctgtctctg aaggaggtgc tgtttctccg 780 gtgggtgagc acttcctgtc cagatgcgga gtttgttttc aaaggcgatg atgatgtgtt 840 tgtgaatact caccacatcc tgaattactt gaatagctta tccaagaaca aagccaaaga 900 tttgtttata ggtgacgtga tccacaatgc tgggcctcat cgggataaga aactgaagta 960 ctacatccca gaagtcttct atactggggt ctacccaccg tatgcaggag gaggtgggtt 1020 cctgtactcc ggagccctgg ccctgagact gtacaatata actgaccggg tccacctcta 1080 tcccatagat gatgtttata ctggaatgtg ccttcagaaa ctgggccttg ttcccgagaa 1140 acacaaaggc ttcaggacat ttgatattga agagaaaaat aaaaaaaata tttgttcata 1200 tgtagatcta atgttagtgc atagcagaaa acctcaagag atgattgata tttggtctca 1260 gttgcagagt cctaatttaa aatgctaacg tgcactggag ctgcatttca caaaaaggcc 1320 tatcctgcct agttcccatg ttgtgctttc acagtagggt gacttctgta tgaagccatc 1380 agccttgatg agtagcatct gaaccctgag ccctcagttc cacacttttg tggccagggg 1440 aaaagctgaa gataattcac catggtcaga tgattggttc tgacccttcc tctggctgcc 1500 agtcctcagt tcctaatttt tacttctcca aaatcatgtt tagaattcga ccatggaggt 1560 cttttttttg tctttatgat ggtatactcc tgcttccatt ttaatgatgg atacagacca 1620 ggtgtttata aactggctac gcaagatttt gtaggacatg attttgtgtt tttgtgaaat 1680 ggaattatgg aattatattt attttcataa gattttgatg ggcttttaaa attggctaga 1740 aaatggactg atgttgaaat tccccgtcac cccaacagta ttctccttgt tactagaacc 1800 catccctttc ttataaaaag aaagccacca tgcaacacat gcagttcatc tcgtctggcc 1860 ttatggccat gagaagggca gaaggttttc ttttacctgt gtttggtttg ctgggtagca 1920 tcatgatggt taattttagt atttggaaat cttgagtgtg attccaaatg gccaactgaa 1980 gactcagtag cctgacagcc atatgggttt gtgaatgttc aatgtgggtc agggaagcat 2040 ttgtgtcttt tgaacttgaa atgaaaagct agatcttgaa ggcattttct taagtggttt 2100 gtcagtttaa aactccagga ttctattctt gccatattat ctatcagatg ttgcttagct 2160 gaagcttttc tgagtagtga tgcttccctg tctcagtgta gaagtacctg tgtttttatt 2220 tattgttcag atcaaagacc aaaacatttt cttaagaata ttttgtgtaa tattttattt 2280 gtatacagtg ttgtttgtga aatatttaac tagagcatga tattttattt tttctcattt 2340 taaattagtt tttttttgag aatttcatac aatgtgtttt gatccatatt cgcctccccc 2400 aactcctccc agatctagcc ccagcatgtt ttaaatgtta agctataaca tatgttgaat 2460 aaagttaact cttatttttt gaattttaaa atttggattg ggggggcaga acggctagag 2520 ttgataaagt tctgccaaat tgttgcttat accttgtatc ttgtaacatg ctttcttgaa 2580 actttttttt gttttgtttt agagggttct cctttgtgct gttggggatt gggggaaaag 2640 tggaaataaa gtgactgtat tttttaatca 2670 <210> 2 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> siRNA-499 S <400> 2 gaagaaatgc gcaaagaa 18 <210> 3 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> siRNA-499 A <400> 3 ttctttgcgc atttcttc 18 <210> 4 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-1101 S <400> 4 ctggaatgtg ccttcagaa 19 <210> 5 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-1101 A <400> 5 ttctgaaggc acattccag 19 <210> 6 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-970 S <400> 6 catcccagaa gtcttctat 19 <210> 7 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-970 A <400> 7 atagaagact tctgggatg 19 <210> 8 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> beta 3gnt2 qPCR F <400> 8 ctggcgatta agtccctcat t 21 <210> 9 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> beta 3gnt2 qPCR R <400> 9 ctggcgatta agtccctcat t 21 <210> 10 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-1 <400> 10 tgttccagta cgcccgggaa 20 <210> 11 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-2 <400> 11 agtctttaaa tctgtccggc 20 <210> 12 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-3 <400> 12 gtagtgagag tcttcttgtt 20 <210> 13 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-4 <400> 13 gttgggcaag acgccccccg 20 <210> 14 <211> 4251 <212> DNA <213> Artificial Sequence <220> <223> Cas9 DNA <400> 14 atggataaga aatactcaat aggactggat attggcacaa atagcgtcgg atgggctgtg 60 atcactgatg aatataaggt tccttctaaa aagttcaagg ttctgggaaa tacagaccgc 120 cacagtatca aaaaaaatct tataggggct cttctgtttg acagtggaga gacagccgaa 180 gctactagac tcaaacggac agctaggaga aggtatacaa gacggaagaa taggatttgt 240 tatctccagg agattttttc aaatgagatg gccaaagtgg atgatagttt ctttcataga 300 cttgaagagt cttttttggt ggaagaagac aagaagcatg aaagacatcc tatttttgga 360 aatatagtgg atgaagttgc ttatcacgag aaatatccaa ctatctatca tctgagaaaa 420 aaattggtgg attctactga taaagccgat ttgcgcctga tctatttggc cctggcccac 480 atgattaagt ttagaggtca ttttttgatt gagggcgatc tgaatcctga taatagtgat 540 gtggacaaac tgtttatcca gttggtgcaa acctacaatc aactgtttga agaaaaccct 600 attaacgcaa gtggagtgga tgctaaagcc attctttctg caagattgag taaatcaaga 660 agactggaaa atctcattgc tcagctcccc ggtgagaaga aaaatggcct gtttgggaat 720 ctcattgctt tgtcattggg tttgacccct aattttaaat caaattttga tttggcagaa 780 gatgctaaac tccagctttc aaaagatact tacgatgatg atctggataa tctgttggct 840 caaattggag atcaatatgc tgatttgttt ttggcagcta agaatctgtc agatgctatt 900 ctgctttcag acatcctgag agtgaatact gaaataacta aggctcccct gtcagcttca 960 atgattaaac gctacgatga acatcatcaa gacttgactc ttctgaaagc cctggttaga 1020 caacaacttc cagaaaagta taaagaaatc ttttttgatc aatcaaaaaa cggatatgca 1080 ggttatattg atggcggcgc aagccaagaa gaattttata aatttatcaa accaattctg 1140 gaaaaaatgg atggtactga ggaactgttg gtgaaactga atagagaaga tttgctgcgc 1200 aagcaacgga cctttgacaa cggctctatt ccccatcaaa ttcacttggg tgagctgcat 1260 gctattttga gaagacaaga agacttttat ccatttctga aagacaatag agagaagatt 1320 gaaaaaatct tgacttttag gattccttat tatgttggtc cattggccag aggcaatagt 1380 aggtttgcat ggatgactcg gaagtctgaa gaaacaatta ccccatggaa ttttgaagaa 1440 gttgtcgata aaggtgcttc agctcaatca tttattgaac gcatgacaaa ctttgataaa 1500 aatcttccaa atgaaaaagt gctgccaaaa catagtttgc tttatgagta ttttaccgtt 1560 tataacgaat tgacaaaggt caaatatgtt actgaaggaa tgagaaaacc agcatttctt 1620 tcaggtgaac agaagaaagc cattgttgat ctgctcttca aaacaaatag gaaagtgacc 1680 gttaagcaac tgaaagaaga ttatttcaaa aaaatagaat gttttgatag tgttgaaatt 1740 tcaggagttg aagatagatt taatgcttca ctgggtacat accatgattt gctgaaaatt 1800 attaaagata aagatttttt ggataatgaa gaaaatgaag acatcctgga ggatattgtt 1860 ctgacattga ccctgtttga agatagggag atgattgagg aaagacttaa aacatacgct 1920 cacctctttg atgataaggt gatgaaacag cttaaaagac gcagatatac tggttgggga 1980 aggttgtcca gaaaattgat taatggtatt agggataagc aatctggcaa aacaatactg 2040 gattttttga aatcagatgg ttttgccaat cgcaatttta tgcagctcat ccatgatgat 2100 agtttgacat ttaaagaaga catccaaaaa gcacaagtgt ctggacaagg cgatagtctg 2160 catgaacata ttgcaaatct ggctggtagc cctgctatta aaaaaggtat tctccagact 2220 gtgaaagttg ttgatgaatt ggtcaaagtg atggggcggc ataagccaga aaatatcgtt 2280 attgaaatgg caagagaaaa tcagacaact caaaagggcc agaaaaattc cagagagagg 2340 atgaaaagaa tcgaagaagg tatcaaagaa ctgggaagtc agattcttaa agagcatcct 2400 gttgaaaata ctcaattgca aaatgaaaag ctctatctct attatctcca aaatggaaga 2460 gatatgtatg tggaccaaga actggatatt aataggctga gtgattatga tgtcgatcac 2520 attgttccac aaagtttcct taaagacgat tcaatagaca ataaggtcct gaccaggtct 2580 gataaaaata gaggtaaatc cgataacgtt ccaagtgaag aagtggtcaa aaagatgaaa 2640 aactattgga gacaacttct gaacgccaag ctgatcactc aaaggaagtt tgataatctg 2700 accaaagctg aaagaggagg tttgagtgaa cttgataaag ctggttttat caaacgccaa 2760 ttggttgaaa ctcgccaaat cactaagcat gtggcacaaa ttttggatag tcgcatgaat 2820 actaaatacg atgaaaatga taaacttatt agagaggtta aagtgattac cctgaaatct 2880 aaactggttt ctgacttcag aaaagatttc caattctata aagtgagaga gattaacaat 2940 taccatcatg cccatgatgc ctatctgaat gccgtcgttg gaactgcttt gattaagaaa 3000 tatccaaaac ttgaaagcga gtttgtctat ggtgattata aagtttatga tgttaggaaa 3060 atgattgcta agtctgagca agaaataggc aaagcaaccg caaagtattt cttttactct 3120 aatatcatga acttcttcaa aacagaaatt acacttgcaa atggagagat tcgcaaacgc 3180 cctctgatcg aaactaatgg ggaaactgga gaaattgtct gggataaagg gagagatttt 3240 gccacagtgc gcaaagtgtt gtccatgccc caagtcaata tcgtcaagaa aacagaagtg 3300 cagacaggcg gattctctaa ggagtcaatt ctgccaaaaa gaaattccga caagctgatt 3360 gctaggaaaa aagactggga cccaaaaaaa tatggtggtt ttgatagtcc aaccgtggct 3420 tattcagtcc tggtggttgc taaggtggaa aaagggaaat ccaagaagct gaaatccgtt 3480 aaagagctgc tggggatcac aattatggaa agaagttcct ttgaaaaaaa tcccattgac 3540 tttctggaag ctaaaggata taaggaagtt aaaaaagacc tgatcattaa actgcctaaa 3600 tatagtcttt ttgagctgga aaacggtagg aaacggatgc tggctagtgc cggagaactg 3660 caaaaaggaa atgagctggc tctgccaagc aaatatgtga attttctgta tctggctagt 3720 cattatgaaa agttgaaggg tagtccagaa gataacgaac aaaaacaatt gtttgtggag 3780 cagcataagc attatctgga tgagattatt gagcaaatca gtgaattttc taagagagtt 3840 attctggcag atgccaatct ggataaagtt cttagtgcat ataacaaaca tagagacaaa 3900 ccaataagag aacaagcaga aaatatcatt catctgttta ccttgaccaa tcttggagca 3960 cccgctgctt ttaaatactt tgatacaaca attgatagga aaagatatac ctctacaaaa 4020 gaagttctgg atgccactct tatccatcaa tccatcactg gtctttatga aacacgcatt 4080 gatttgagtc agctgggagg tgaccccaag aaaaaacgca aggtggaaga tcctaagaaa 4140 aagcggaaag tggacacgcg tacgcggccg ctcgagcaga aactcatctc agaagaggat 4200 ctggcagcaa atgatatcct ggattacaag gatgacgacg ataaggttta a 4251 <210> 15 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15007 <400> 15 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgt gttccagtac gcccgggaag 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagaggt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacga attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gacgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 16 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15181 <400> 16 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcga gtctttaaat ctgtccggcg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagaggt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacga attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gacgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 17 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15385 <400> 17 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgg tagtgagagt cttcttgttg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagaggt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacga attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gacgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 18 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15402 <400> 18 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgg ttgggcaaga cgccccccgg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagaggt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacga attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gacgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 19 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> indel F <400> 19 gcattgtgga tcacgtcacc tataaac 27 <210> 20 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> indel R <400> 20 ccagatatga gaaatgagtg ttggacg 27 <110> Korea Advanced Institute of Science and Technology <120> Method for preparing recombinant glycoproteins with improved          N-glycan antennary structure by inhibiting biosynthesis          폴리 라코산 <130> 2017P-07-017 <150> KR 10-2016-0100674 <151> 2016-08-08 <160> 20 <170> KoPatentin <210> 1 <211> 2670 <212> RNA <213> Cricetulus griseus <400> 1 tcagatttat gtctgataat ccacactgag atgtcccacc cagagctgtt tgggcacctt 60 cgtagtatga gctagcttat aaaagatatg agaaatgagt gttggacgtc gaagaataaa 120 gttgttgggt atcctgatga tggcaaatgt cttcatttat ttgattgtgg aagtctccaa 180 aaatagtagc caagaaaaaa atggaaaggg gggagtaata atacccaaag aaaagttctg 240 gaagatattc agcccttccc gggcgtactg gaacagagag caagagaaac tgaacaagtg 300 gtacaatccc attctgaaca ggctggccaa ccagacaggg gatttgtatt cgtctccaaa 360 tataagtcat ctgggctatt gtgaacctga cccaagggtc atgacagctg tgacagattt 420 taataacctg ccggacagat ttaaagactt cctcttgtat ttgagatgcc gaaattactc 480 actgcttata gatcaaccga agaaatgcgc aaagaaaccc ttcttactgc tggcgattaa 540 gtccctcatt ccacattttg ccagaaggca agcaattcgg gaatcttggg gcagagaaac 600 caatgtgggg aaccagacagt tagtgagagt cttcttgttg ggcaagacgc cccccgagga 660 caaccaccct gacctttcag acatgctgaa gtttgagagt gagaggcacc aggacattct 720 catgtggaac tatagagaca ctttcttcaa cctgtctctg aaggaggtgc tgtttctccg 780 gtgggtgagc acttcctgtc cagatgcgga gtttgttttc aaaggcgatg atgatgtgtt 840 tgtgaatact caccacatcc tgaattactt gaatagctta tccaagaaca aagccaaaga 900 tttgtttata ggtgacgtga tccacaatgc tgggcctcat cgggataaga aactgaagta 960 ctacatccca gaagtcttct atactggggt ctacccaccg tatgcaggag gaggtgggtt 1020 cctgtactcc ggagccctgg ccctgagact gtacaatata actgaccggg tccacctcta 1080 tcccatagat gatgtttata ctggaatgtg ccttcagaaa ctgggccttg ttcccgagaa 1140 acacaaaggc ttcaggacat ttgatattga agagaaaaat aaaaaaaata tttgttcata 1200 tgtagatcta atgttagtgc atagcagaaa acctcaagag atgattgata tttggtctca 1260 gttgcagagt cctaatttaa aatgctaacg tgcactggag ctgcatttca caaaaaggcc 1320 tatcctgcct agttcccatg ttgtgctttc acagtagggt gacttctgta tgaagccatc 1380 agccttgatg agtagcatct gaaccctgag ccctcagttc cacacttttg tggccagggg 1440 aaaagctgaa gataattcac catggtcaga tgattggttc tgacccttcc tctggctgcc 1500 agtcctcagt tcctaatttt tacttctcca aaatcatgtt tagaattcga ccatggaggt 1560 cttttttttg tctttatgat ggtatactcc tgcttccatt ttaatgatgg atacagacca 1620 ggtgtttata aactggctac gcaagatttt gtaggacatg attttgtgtt tttgtgaaat 1680 ggaattatgg aattatattt attttcataa gattttgatg ggcttttaaa attggctaga 1740 aaatggactg atgttgaaat tccccgtcac cccaacagta ttctccttgt tactagaacc 1800 catccctttc ttataaaaag aaagccacca tgcaacacat gcagttcatc tcgtctggcc 1860 ttatggccat gagaagggca gaaggttttc ttttacctgt gtttggtttg ctgggtagca 1920 tcatgatggt taattttagt atttggaaat cttgagtgtg attccaaatg gccaactgaa 1980 gactcagtag cctgacagcc atatgggttt gtgaatgttc aatgtgggtc agggaagcat 2040 ttgtgtcttt tgaacttgaa atgaaaagct agatcttgaa ggcattttct taagtggttt 2100 gtcagtttaa aactccagga ttctattctt gccatattat ctatcagatg ttgcttagct 2160 gaagcttttc tgagtagtga tgcttccctg tctcagtgta gaagtacctg tgtttttatt 2220 tattgttcag atcaaagacc aaaacatttt cttaagaata ttttgtgtaa tattttattt 2280 gtatacagtg ttgtttgtga aatatttaac tagagcatga tattttattt tttctcattt 2340 taaattagtt tttttttgag aatttcatac aatgtgtttt gatccatatt cgcctccccc 2400 aactcctccc agatctagcc ccagcatgtt ttaaatgtta agctataaca tatgttgaat 2460 aaagttaact cttatttttt gaattttaaa atttggattg ggggggcaga acggctagag 2520 ttgataaagt tctgccaaat tgttgcttat accttgtatc ttgtaacatg ctttcttgaa 2580 actttttttt gttttgtttt agagggttct cctttgtgct gttggggatt gggggaaaag 2640 tggaaataaa gtgactgtat tttttaatca 2670 <210> 2 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> siRNA-499 S <400> 2 gaagaaatgc gcaaagaa 18 <210> 3 <211> 18 <212> DNA <213> Artificial Sequence <220> <223> siRNA-499A <400> 3 ttctttgcgc atttcttc 18 <210> 4 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-1101 S <400> 4 ctggaatgtg ccttcagaa 19 <210> 5 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-1101A <400> 5 ttctgaaggc acattccag 19 <210> 6 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-970 S <400> 6 catcccagaa gtcttctat 19 <210> 7 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> siRNA-970A <400> 7 atagaagact tctgggatg 19 <210> 8 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> beta 3gnt2 qPCR F <400> 8 ctggcgatta agtccctcat t 21 <210> 9 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> beta 3gnt2 qPCR R <400> 9 ctggcgatta agtccctcat t 21 <210> 10 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-1 <400> 10 tgttccagta cgcccgggaa 20 <210> 11 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-2 <400> 11 agtctttaaa tctgtccggc 20 <210> 12 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-3 <400> 12 gtagtgagag tcttcttgtt 20 <210> 13 <211> 20 <212> DNA <213> Artificial Sequence <220> <223> gRNA-4 <400> 13 gttgggcaag acgccccccg 20 <210> 14 <211> 4251 <212> DNA <213> Artificial Sequence <220> <223> Cas9 DNA <400> 14 atggataaga aatactcaat aggactggat attggcacaa atagcgtcgg atgggctgtg 60 atcactgatg aatataaggt tccttctaaa aagttcaagg ttctgggaaa tacagaccgc 120 cacagtatca aaaaaaatct tataggggct cttctgtttg acagtggaga gacagccgaa 180 gctactagac tcaaacggac agctaggaga aggtatacaa gacggaagaa taggatttgt 240 tatctccagg agattttttc aaatgagatg gccaaagtgg atgatagttt ctttcataga 300 cttgaagagt cttttttggt ggaagaagac aagaagcatg aaagacatcc tatttttgga 360 aatatagtgg atgaagttgc ttatcacgag aaatatccaa ctatctatca tctgagaaaa 420 aaattggtgg attctactga taaagccgat ttgcgcctga tctatttggc cctggcccac 480 atgattaagt ttagaggtca ttttttgatt gagggcgatc tgaatcctga taatagtgat 540 gtggacaaac tgtttatcca gttggtgcaa acctacaatc aactgtttga agaaaaccct 600 attaacgcaa gtggagtgga tgctaaagcc attctttctg caagattgag taaatcaaga 660 agactggaaa atctcattgc tcagctcccc ggtgagaaga aaaatggcct gtttgggaat 720 ctcattgctt tgtcattggg tttgacccct aattttaaat caaattttga tttggcagaa 780 gatgctaaac tccagctttc aaaagatact tacgatgatg atctggataa tctgttggct 840 caaattggag atcaatatgc tgatttgttt ttggcagcta agaatctgtc agatgctatt 900 ctgctttcag acatcctgag agtgaatact gaaataacta aggctcccct gtcagcttca 960 atgattaaac gctacgatga acatcatcaa gacttgactc ttctgaaagc cctggttaga 1020 caacaacttc cagaaaagta taaagaaatc ttttttgatc aatcaaaaaa cggatatgca 1080 ggttatattg atggcggcgc aagccaagaa gaattttata aatttatcaa accaattctg 1140 gaaaaaatgg atggtactga ggaactgttg gtgaaactga atagagaaga tttgctgcgc 1200 aagcaacgga cctttgacaa cggctctatt ccccatcaaa ttcacttggg tgagctgcat 1260 gctattttga gaagacaaga agacttttat ccatttctga aagacaatag agagaagatt 1320 gaaaaaatct tgacttttag gattccttat tatgttggtc cattggccag aggcaatagt 1380 aggtttgcat ggatgactcg gaagtctgaa gaaacaatta ccccatggaa ttttgaagaa 1440 gttgtcgata aaggtgcttc agctcaatca tttattgaac gcatgacaaa ctttgataaa 1500 aatcttccaa atgaaaaagt gctgccaaaa catagtttgc tttatgagta ttttaccgtt 1560 tataacgaat tgacaaaggt caaatatgtt actgaaggaa tgagaaaacc agcatttctt 1620 tcaggtgaac agaagaaagc cattgttgat ctgctcttca aaacaaatag gaaagtgacc 1680 gttaagcaac tgaaagaaga ttatttcaaa aaaatagaat gttttgatag tgttgaaatt 1740 tcaggagttg aagatagatt taatgcttca ctgggtacat accatgattt gctgaaaatt 1800 attaaagata aagatttttt ggataatgaa gaaaatgaag acatcctgga ggatattgtt 1860 ctgacattga ccctgtttga agatagggag atgattgagg aaagacttaa aacatacgct 1920 cacctctttg atgataaggt gatgaaacag cttaaaagac gcagatatac tggttgggga 1980 aggttgtcca gaaaattgat taatggtatt agggataagc aatctggcaa aacaatactg 2040 gattttttga aatcagatgg ttttgccaat cgcaatttta tgcagctcat ccatgatgat 2100 agtttgacat ttaaagaaga catccaaaaa gcacaagtgt ctggacaagg cgatagtctg 2160 catgaacata ttgcaaatct ggctggtagc cctgctatta aaaaaggtat tctccagact 2220 gtgaaagttg ttgatgaatt ggtcaaagtg atggggcggc ataagccaga aaatatcgtt 2280 attgaaatgg caagagaaaa tcagacaact caaaagggcc agaaaaattc cagagagagg 2340 atgaaaagaa tcgaagaagg tatcaaagaa ctgggaagtc agattcttaa agagcatcct 2400 gttgaaaata ctcaattgca aaatgaaaag ctctatctct attatctcca aaatggaaga 2460 gatatgtatg tggaccaaga actggatatt aataggctga gtgattatga tgtcgatcac 2520 attgttccac aaagtttcct taaagacgat tcaatagaca ataaggtcct gaccaggtct 2580 gataaaaata gaggtaaatc cgataacgtt ccaagtgaag aagtggtcaa aaagatgaaa 2640 aactattgga gacaacttct gaacgccaag ctgatcactc aaaggaagtt tgataatctg 2700 accaaagctg aaagaggagg tttgagtgaa cttgataaag ctggttttat caaacgccaa 2760 ttggttgaaa ctcgccaaat cactaagcat gtggcacaaa ttttggatag tcgcatgaat 2820 actaaatacg atgaaaatga taaacttatt agagaggtta aagtgattac cctgaaatct 2880 aaactggttt ctgacttcag aaaagatttc caattctata aagtgagaga gattaacaat 2940 taccatcatg cccatgatgc ctatctgaat gccgtcgttg gaactgcttt gattaagaaa 3000 tatccaaaac ttgaaagcga gtttgtctat ggtgattata aagtttatga tgttaggaaa 3060 atgattgcta agtctgagca agaaataggc aaagcaaccg caaagtattt cttttactct 3120 aatatcatga acttcttcaa aacagaaatt acacttgcaa atggagagat tcgcaaacgc 3180 cctctgatcg aaactaatgg ggaaactgga gaaattgtct gggataaagg gagagatttt 3240 gccacagtgc gcaaagtgtt gtccatgccc caagtcaata tcgtcaagaa aacagaagtg 3300 cagacaggcg gattctctaa ggagtcaatt ctgccaaaaa gaaattccga caagctgatt 3360 gctaggaaaa aagactggga cccaaaaaaa tatggtggtt ttgatagtcc aaccgtggct 3420 tattcagtcc tggtggttgc taaggtggaa aaagggaaat ccaagaagct gaaatccgtt 3480 aaagagctgc tggggatcac aattatggaa agaagttcct ttgaaaaaaa tcccattgac 3540 tttctggaag ctaaaggata taaggaagtt aaaaaagacc tgatcattaa actgcctaaa 3600 tatagtcttt ttgagctgga aaacggtagg aaacggatgc tggctagtgc cggagaactg 3660 caaaaaggaa atgagctggc tctgccaagc aaatatgtga attttctgta tctggctagt 3720 cattatgaaa agttgaaggg tagtccagaa gataacgaac aaaaacaatt gtttgtggag 3780 cagcataagc attatctgga tgagattatt gagcaaatca gtgaattttc taagagagtt 3840 attctggcag atgccaatct ggataaagtt cttagtgcat ataacaaaca tagagacaaa 3900 ccaataagag aacaagcaga aaatatcatt catctgttta ccttgaccaa tcttggagca 3960 cccgctgctt ttaaatactt tgatacaaca attgatagga aaagatatac ctctacaaaa 4020 gaagttctgg atgccactct tatccatcaa tccatcactg gtctttatga aacacgcatt 4080 gatttgagtc agctgggagg tgaccccaag aaaaaacgca aggtggaaga tcctaagaaa 4140 aagcggaaag tggacacgcg tacgcggccg ctcgagcaga aactcatctc agaagaggat 4200 ctggcagcaa atgatatcct ggattacaag gatgacgacg ataaggttta a 4251 <210> 15 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15007 <400> 15 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgt gttccagtac gcccgggaag 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagagt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacg attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gcgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 16 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15181 <400> 16 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcga gtctttaaat ctgtccggcg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagagt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacg attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gcgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 17 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15385 <400> 17 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgg tagtgagagt cttcttgttg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagagt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacg attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gcgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 18 <211> 10458 <212> DNA <213> Artificial Sequence <220> <223> pCas-Guide-EF1a-GFP-15402 <400> 18 gaattcccca gtggaaagac gcgcaggcaa aacgcaccac gtgacggagc gtgaccgcgc 60 gccgagcgcg cgccaaggtc gggcaggaag agggcctatt tcccatgatt ccttcatatt 120 tgcatatacg atacaaggct gttagagaga taattagaat taatttgact gtaaacacaa 180 agatattagt acaaaatacg tgacgtagaa agtaataatt tcttgggtag tttgcagttt 240 taaaattatg ttttaaaatg gactatcata tgcttaccgt aacttgaaag tatttcgatt 300 tcttgggttt atatatcttg tggaaaggac gcgggatcgg ttgggcaaga cgccccccgg 360 ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 420 gcaccgagtc ggtgcttttt ttggtgtaca cgtgaggctc cggtgcccgt cagtgggcag 480 agcgcacatc gcccacagtc cccgagaagt tggggggagg ggtcggcaat tgaaccggtg 540 cctagagaag gtggcgcggg gtaaactggg aaagtgatgt cgtgtactgg ctccgccttt 600 ttcccgaggg tgggggagaa ccgtatataa gtgcagtagt cgccgtgaac gttctttttc 660 gcaacgggtt tgccgccaga acacaggtaa gtgccgtgtg tggttcccgc gggcctggcc 720 tctttacggg ttatggccct tgcgtgcctt gaattacttc cacctggctg cagtacgtga 780 ttcttgatcc cgagcttcgg gttggaagtg ggtgggagag ttcgaggcct tgcgcttaag 840 gagccccttc gcctcgtgct tgagttgagg cctggcctgg gcgctggggc cgccgcgtgc 900 gaatctggtg gcaccttcgc gcctgtctcg ctgctttcga taagtctcta gccatttaaa 960 atttttgatg acctgctgcg acgctttttt tctggcaaga tagtcttgta aatgcgggcc 1020 aagatctgca cactggtatt tcggtttttg gggccgcggg cggcgacggg gcccgtgcgt 1080 cccagcgcac atgttcggcg aggcggggcc tgcgagcgcg gccaccgaga atcggacggg 1140 ggtagtctca agctggccgg cctgctctgg tgcctggcct cgcgccgccg tgtatcgccc 1200 cgccctgggc ggcaaggctg gcccggtcgg caccagttgc gtgagcggaa agatggccgc 1260 ttcccggccc tgctgcaggg agctcaaaat ggaggacgcg gcgctcggga gagcgggcgg 1320 gtgagtcacc cacacaaagg aaaagggcct ttccgtcctc agccgtcgct tcatgtgact 1380 ccacggagta ccgggcgccg tccaggcacc tcgattagtt ctcgagcttt tggagtacgt 1440 cgtctttagg ttggggggag gggttttatg cgatggagtt tccccacact gagtgggtgg 1500 agactgaagt taggccagct tggcacttga tgtaattctc cttggaattt gccctttttg 1560 agtttggatc ttggttcatt ctcaagcctc agacagtggt tcaaagtttt tttcttccat 1620 ttcaggtgtc gtgactatag ggcggccgga cgtgacaaat ggaagtagca cgcctcacta 1680 ggctcgtgca gatggacagc accgctgcag ccatggagag cgacgagagc ggcctgcccg 1740 ccatggagat cgagtgccgc atcaccggca ccctgaacgg cgtggagttc gagctggtgg 1800 gcggcggaga gggcaccccc gagcagggcc gcatgaccaa caagatgaag agcaccaaag 1860 gcgccctgac cttcagcccc tacctgctga gccacgtgat gggctacggc ttctaccact 1920 tcggcaccta ccccagcggc tacgagaacc ccttcctgca cgccatcaac aacggcggct 1980 acaccaacac ccgcatcgag aagtacgagg acggcggcgt gctgcacgtg agcttcagct 2040 accgctacga ggccggccgc gtgatcggcg acttcaaggt gatgggcacc ggcttccccg 2100 aggacagcgt gatcttcacc gacaagatca tccgcagcaa cgccaccgtg gagcacctgc 2160 accccatggg cgataacgat ctggatggca gcttcacccg caccttcagc ctgcgcgacg 2220 gcggctacta cagctccgtg gtggacagcc acatgcactt caagagcgcc atccacccca 2280 gcatcctgca gaacgggggc cccatgttcg ccttccgccg cgtggaggag gatcacagca 2340 acaccgagct gggcatcgtg gagtaccagc acgccttcaa gaccccggat gcagatgccg 2400 gtgaagaaag agtttaatcg atgatatcag atccccggga tgcagaaatt gatgatctat 2460 taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg ttaagaaggg 2520 tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt gggggtgggg 2580 tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt tatgataatg 2640 tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc agctcattcc 2700 tcccactcat gatctataga tctatagatc tctcgtggga tcattgtttt tctcttgatt 2760 cccactttgt ggttctaagt actgtggttt ccaaatgtgt cagtttcata gcctgaagaa 2820 cgagatcagc agcctctgtt ccacatacac ttcattctca gtattgtttt gccaagttct 2880 aattccatca gaagctggtc gagatccgga acccttaata taacttcgta taatgtatgc 2940 tatacgaagt tattaggtcc actagttatt aatagtaatc aattacgggg tcattagttc 3000 atagcccata tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac 3060 cgcccaacga cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa 3120 tagggacttt ccattgacgt caatgggtgg agtatttacg gtaaactgcc cacttggcag 3180 tacatcaagt gtatcatatg ccaagtccgc cccctattga cgtcaatgac ggtaaatggc 3240 ccgcctggca ttatgcccag tacatgacct tacgggactt tcctacttgg cagtacatct 3300 acgtattagt catcgctatt accatggtga tgcggttttg gcagtacacc aatgggcgtg 3360 gatagcggtt tgactcacgg ggatttccaa gtctccaccc cattgacgtc aatgggagtt 3420 tgttttggca ccaaaatcaa cgggactttc caaaatgtcg taataacccc gccccgttga 3480 cgcaaatggg cggtaggcgt gtacggtggg aggtctatat aagcagagct cgtttagtga 3540 accgtcagaa ttttgtaata cgactcacta tagggcggcc gggaattcgt cgactggaac 3600 cggtaccgag gagatctgcc gccgcgatcg ccatggataa gaaatactca ataggactgg 3660 atattggcac aaatagcgtc ggatgggctg tgatcactga tgaatataag gttccttcta 3720 aaaagttcaa ggttctggga aatacagacc gccacagtat caaaaaaaat cttatagggg 3780 ctcttctgtt tgacagtgga gagacagccg aagctactag actcaaacgg acagctagga 3840 gaaggtatac aagacggaag aataggattt gttatctcca ggagattttt tcaaatgaga 3900 tggccaaagt ggatgatagt ttctttcata gacttgaaga gtcttttttg gtggaagaag 3960 acaagaagca tgaaagacat cctatttttg gaaatatagt ggatgaagtt gcttatcacg 4020 agaaatatcc aactatctat catctgagaa aaaaattggt ggattctact gataaagccg 4080 atttgcgcct gatctatttg gccctggccc acatgattaa gtttagagt cattttttga 4140 ttgagggcga tctgaatcct gataatagtg atgtggacaa actgtttatc cagttggtgc 4200 aaacctacaa tcaactgttt gaagaaaacc ctattaacgc aagtggagtg gatgctaaag 4260 ccattctttc tgcaagattg agtaaatcaa gaagactgga aaatctcatt gctcagctcc 4320 ccggtgagaa gaaaaatggc ctgtttggga atctcattgc tttgtcattg ggtttgaccc 4380 ctaattttaa atcaaatttt gatttggcag aagatgctaa actccagctt tcaaaagata 4440 cttacgatga tgatctggat aatctgttgg ctcaaattgg agatcaatat gctgatttgt 4500 ttttggcagc taagaatctg tcagatgcta ttctgctttc agacatcctg agagtgaata 4560 ctgaaataac taaggctccc ctgtcagctt caatgattaa acgctacgat gaacatcatc 4620 aagacttgac tcttctgaaa gccctggtta gacaacaact tccagaaaag tataaagaaa 4680 tcttttttga tcaatcaaaa aacggatatg caggttatat tgatggcggc gcaagccaag 4740 aagaatttta taaatttatc aaaccaattc tggaaaaaat ggatggtact gaggaactgt 4800 tggtgaaact gaatagagaa gatttgctgc gcaagcaacg gacctttgac aacggctcta 4860 ttccccatca aattcacttg ggtgagctgc atgctatttt gagaagacaa gaagactttt 4920 atccatttct gaaagacaat agagagaaga ttgaaaaaat cttgactttt aggattcctt 4980 attatgttgg tccattggcc agaggcaata gtaggtttgc atggatgact cggaagtctg 5040 aagaaacaat taccccatgg aattttgaag aagttgtcga taaaggtgct tcagctcaat 5100 catttattga acgcatgaca aactttgata aaaatcttcc aaatgaaaaa gtgctgccaa 5160 aacatagttt gctttatgag tattttaccg tttataacg attgacaaag gtcaaatatg 5220 ttactgaagg aatgagaaaa ccagcatttc tttcaggtga acagaagaaa gccattgttg 5280 atctgctctt caaaacaaat aggaaagtga ccgttaagca actgaaagaa gattatttca 5340 aaaaaataga atgttttgat agtgttgaaa tttcaggagt tgaagataga tttaatgctt 5400 cactgggtac ataccatgat ttgctgaaaa ttattaaaga taaagatttt ttggataatg 5460 aagaaaatga agacatcctg gaggatattg ttctgacatt gaccctgttt gaagataggg 5520 agatgattga ggaaagactt aaaacatacg ctcacctctt tgatgataag gtgatgaaac 5580 agcttaaaag acgcagatat actggttggg gaaggttgtc cagaaaattg attaatggta 5640 ttagggataa gcaatctggc aaaacaatac tggatttttt gaaatcagat ggttttgcca 5700 atcgcaattt tatgcagctc atccatgatg atagtttgac atttaaagaa gacatccaaa 5760 aagcacaagt gtctggacaa ggcgatagtc tgcatgaaca tattgcaaat ctggctggta 5820 gccctgctat taaaaaaggt attctccaga ctgtgaaagt tgttgatgaa ttggtcaaag 5880 tgatggggcg gcataagcca gaaaatatcg ttattgaaat ggcaagagaa aatcagacaa 5940 ctcaaaaggg ccagaaaaat tccagagaga ggatgaaaag aatcgaagaa ggtatcaaag 6000 aactgggaag tcagattctt aaagagcatc ctgttgaaaa tactcaattg caaaatgaaa 6060 agctctatct ctattatctc caaaatggaa gagatatgta tgtggaccaa gaactggata 6120 ttaataggct gagtgattat gatgtcgatc acattgttcc acaaagtttc cttaaagacg 6180 attcaataga caataaggtc ctgaccaggt ctgataaaaa tagaggtaaa tccgataacg 6240 ttccaagtga agaagtggtc aaaaagatga aaaactattg gagacaactt ctgaacgcca 6300 agctgatcac tcaaaggaag tttgataatc tgaccaaagc tgaaagagga ggtttgagtg 6360 aacttgataa agctggtttt atcaaacgcc aattggttga aactcgccaa atcactaagc 6420 atgtggcaca aattttggat agtcgcatga atactaaata cgatgaaaat gataaactta 6480 ttagagaggt taaagtgatt accctgaaat ctaaactggt ttctgacttc agaaaagatt 6540 tccaattcta taaagtgaga gagattaaca attaccatca tgcccatgat gcctatctga 6600 atgccgtcgt tggaactgct ttgattaaga aatatccaaa acttgaaagc gagtttgtct 6660 atggtgatta taaagtttat gatgttagga aaatgattgc taagtctgag caagaaatag 6720 gcaaagcaac cgcaaagtat ttcttttact ctaatatcat gaacttcttc aaaacagaaa 6780 ttacacttgc aaatggagag attcgcaaac gccctctgat cgaaactaat ggggaaactg 6840 gagaaattgt ctgggataaa gggagagatt ttgccacagt gcgcaaagtg ttgtccatgc 6900 cccaagtcaa tatcgtcaag aaaacagaag tgcagacagg cggattctct aaggagtcaa 6960 ttctgccaaa aagaaattcc gacaagctga ttgctaggaa aaaagactgg gacccaaaaa 7020 aatatggtgg ttttgatagt ccaaccgtgg cttattcagt cctggtggtt gctaaggtgg 7080 aaaaagggaa atccaagaag ctgaaatccg ttaaagagct gctggggatc acaattatgg 7140 aaagaagttc ctttgaaaaa aatcccattg actttctgga agctaaagga tataaggaag 7200 ttaaaaaaga cctgatcatt aaactgccta aatatagtct ttttgagctg gaaaacggta 7260 ggaaacggat gctggctagt gccggagaac tgcaaaaagg aaatgagctg gctctgccaa 7320 gcaaatatgt gaattttctg tatctggcta gtcattatga aaagttgaag ggtagtccag 7380 aagataacga acaaaaacaa ttgtttgtgg agcagcataa gcattatctg gatgagatta 7440 ttgagcaaat cagtgaattt tctaagagag ttattctggc agatgccaat ctggataaag 7500 ttcttagtgc atataacaaa catagagaca aaccaataag agaacaagca gaaaatatca 7560 ttcatctgtt taccttgacc aatcttggag cacccgctgc ttttaaatac tttgatacaa 7620 caattgatag gaaaagatat acctctacaa aagaagttct ggatgccact cttatccatc 7680 aatccatcac tggtctttat gaaacacgca ttgatttgag tcagctggga ggtgacccca 7740 agaaaaaacg caaggtggaa gatcctaaga aaaagcggaa agtggacacg cgtacgcggc 7800 cgctcgagca gaaactcatc tcagaagagg atctggcagc aaatgatatc ctggattaca 7860 aggatgacga cgataaggtt taaacggccg gccgcggtca tagctgtttc ctgaacagat 7920 cccgggtggc atccctgtga cccctcccca gtgcctctcc tggccctgga agttgccact 7980 ccagtgccca ccagccttgt cctaataaaa ttaagttgca tcattttgtc tgactaggtg 8040 tccttctata atattatggg gtggaggggg gtggtatgga gcaaggggca agttgggaag 8100 acaacctgta gggcctgcgg ggtctattgg gaaccaagct ggagtgcagt ggcacaatct 8160 tggctcactg caatctccgc ctcctgggtt caagcgattc tcctgcctca gcctcccgag 8220 ttgttgggat tccaggcatg catgaccagg ctcagctaat ttttgttttt ttggtagagg 8280 cggggtttca ccatattggc caggctggtc tccaactcct aatctcaggt gatctaccca 8340 ccttggcctc ccaaattgct gggattacag gcgtgaacca ctgctccctt ccctgtcctt 8400 ctgattttaa aataactata ccagcaggag gacgtccaga cacagcatag gctacctggc 8460 catgcccaac cggtgggaca tttgagttgc ttgcttggca ctgtcctctc atgcgttggg 8520 tccactcagt agatgcctgt tgaattgggt acgcggccag cggcgagcgg tatcagctca 8580 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtc 8640 cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 8700 aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 8760 tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 8820 ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat 8880 ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 8940 cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 9000 ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 9060 gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt 9120 atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 9180 aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 9240 aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 9300 gcgcgtaac tcacgttaag ggattttggt catgagatta tcaaaaagga tcttcaccta 9360 gatccttttg cggccgcaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 9420 accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 9480 ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 9540 gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 9600 agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 9660 ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 9720 ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 9780 gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 9840 ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 9900 tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 9960 tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 10020 cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 10080 tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 10140 gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 10200 tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 10260 ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 10320 attgtctcat gatgatatat ttttatcttg tgcaatgtaa catcagagat tttgagacac 10380 gggccagagc tgccaggaaa cagctatgac catgtaatac gactcactat aggggatatc 10440 agctggatgg cagttaac 10458 <210> 19 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> indel F <400> 19 gcattgtgga tcacgtcacc tataaac 27 <210> 20 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> indole R <400> 20 ccagatatga gaaatgagtg ttggacg 27

Claims (19)

당단백질을 생성하는 세포주에서 β3gnt2(UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) 유전자의 발현을 녹-다운(knock-down)시키거나, β3gnt2 유전자를 녹-아웃(knock-out)시키는 단계를 포함하는, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The expression of β3gnt2 (UDP-GlcNAc: betaGal beta-1,3-N-acetylglucosaminyltransferase 2) gene is knocked down or the β3gnt2 gene is knocked out ), Wherein the recombinant glycoprotein has an increased half-life.
삭제delete 제 1항에 있어서, 상기 β3gnt2 유전자의 mRNA는 서열번호 1로 기재되는 염기서열로 구성되는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
2. The method according to claim 1, wherein the mRNA of the? 3gnt2 gene is a nucleotide sequence as set forth in SEQ ID NO: 1, wherein the recombinant glycoprotein has an increased half-life.
제 1항에 있어서, 상기 β3gnt2 유전자 발현의 녹-다운은 β3gnt2 유전자 억제제를 처리하거나, 또는 β3gnt2 mRNA에 결합하는 안티센스 뉴클레오티드, siRNA, shRNA 및 miRNA로 구성된 군으로부터 선택되는 어느 하나를 당단백질을 생산하는 세포주에 형질감염시키는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The method according to claim 1, wherein the rust-down of the? 3gnt2 gene expression comprises treating the β3gnt2 gene inhibitor or producing any one selected from the group consisting of antisense nucleotides, siRNA, shRNA and miRNA binding to β3gnt2 mRNA, A recombinant cell line producing a recombinant glycoprotein with increased half-life.
제 4항에 있어서, 상기 siRNA는 서열번호 2, 서열번호 4 및 서열번호 6으로 구성된 군으로부터 선택되는 어느 하나로 기재되는 염기서열을 포함하는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
5. The recombinant cell line according to claim 4, wherein the siRNA comprises a nucleotide sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 6. &Lt; / RTI &gt;
제 1항에 있어서, 상기 β3gnt2 유전자의 녹-아웃은 재조합 벡터를 당단백질을 생성하는 세포주에 형질전환시키는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법으로,
여기서 상기 재조합 벡터는
서열번호 10 내지 13으로 구성된 군으로부터 선택되는 어느 하나의 가이드 RNA(guide RNA; gRNA)를 암호화하는 염기서열; 및
서열번호 14로 기재되는 염기서열로 구성되는 Cas9(CRISPR associated protein 9) 유전자를 포함하는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The method according to claim 1, wherein the β3gnt2 gene knock-out transforms a recombinant vector into a cell line producing a glycoprotein, wherein the recombinant vector produces a recombinant glycoprotein with an increased half-life,
Wherein the recombinant vector comprises
A nucleotide sequence encoding any one of the guide RNAs (gRNA) selected from the group consisting of SEQ ID NOS: 10 to 13; And
And a Cas9 (CRISPR associated protein 9) gene consisting of the nucleotide sequence shown in SEQ ID NO: 14. The method for producing a recombinant cell line according to claim 1,
제 6항에 있어서, 상기 재조합 벡터는 Cas9 유전자와 형광단백질을 코딩하는 유전자가 결합되어 있는 구조를 포함하는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
[Claim 7] The method according to claim 6, wherein the recombinant vector comprises a Cas9 gene and a gene encoding a fluorescent protein.
제 6항에 있어서, 상기 재조합 벡터는 서열번호 15 내지 18로 구성되는 군으로부터 선택되는 어느 하나의 염기서열을 포함하는 것인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
7. The method according to claim 6, wherein the recombinant vector comprises any one of the nucleotide sequences selected from the group consisting of SEQ ID NOS: 15 to 18, wherein the recombinant vector produces an increased half-life of the recombinant glycoprotein.
제 1항에 있어서, 상기 당단백질은 에리스로포이에틴(erythropoietin), 트롬보포이에틴(thrombopoietin), 알파-안티트립신(alpha-antitrypsin), 콜린에스테라제(cholinesterase), 융모성 고나도트로핀(chorionic gonadotropin), CTLA4Ig, 인자 Ⅷ(Factor Ⅷ), 감마-글루타밀트랜스퍼라아제(gamma-glutamyltransferase), 과립구 콜로니 자극인자(granulocyte colony-stimulating Factor, G-CSF) 및 황체형성호르몬(luteinizing hormone, LH)으로 구성된 군으로부터 선택되는 어느 하나인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The method of claim 1, wherein the glycoprotein is selected from the group consisting of erythropoietin, thrombopoietin, alpha-antitrypsin, cholinesterase, chorionic gonadotropin ), CTLA4Ig, Factor VIII, gamma-glutamyltransferase, granulocyte colony-stimulating factor (G-CSF) and luteinizing hormone (LH) Wherein the recombinant glycoprotein is any one selected from the group consisting of the recombinant cell line and the recombinant cell line.
제 1항에 있어서, 상기 세포주는 포유동물 세포(mammalian cells), 효모 세포(yeast cells) 및 곤충 세포(insect cells)로 구성된 군으로부터 선택되는 어느 하나로부터 제조되는, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The method of claim 1, wherein the cell line is a recombinant glycoprotein with an increased half-life, which is produced from any one selected from the group consisting of mammalian cells, yeast cells and insect cells. Producing a recombinant cell line.
제 1항에 있어서, 상기 세포는 중국 햄스터 난소 세포(chinese hamster ovary cells; CHO), HT-1080, 인간 림프아구(human lymphoblastoid), SP2/0(마우스 골수종), NS0(마우스 골수종), 베이비 햄스터 신장세포(baby hamster kidney cells; BHK), 인간 배아 신장세포(human embryonic kidney cells; HEK), PERC.6(인간망막세포) 및 EC2-1H9로 구성된 군으로부터 선택되는 어느 하나인, 반감기가 증가된 재조합 당단백질을 생산하는 재조합 세포주의 제조방법.
The method of claim 1, wherein the cells are selected from the group consisting of Chinese hamster ovary cells (CHO), HT-1080, human lymphoblastoid, SP2 / 0 (mouse myeloma), NS0 (mouse myeloma) Wherein the antibody is any one selected from the group consisting of human hamster kidney cells (BHK), human embryonic kidney cells (HEK), PERC.6 (human retinal cells), and EC2-1H9 A method for producing a recombinant cell line that produces a recombinant glycoprotein.
제 1항의 방법으로 제조된, 반감기가 증가된 재조합 당단백질을 생산하는 세포주.
A cell line produced by the method of claim 1 which produces an increased half-life of recombinant glycoprotein.
1) 제 12항의 재조합 세포주를 배양하는 단계; 및
2) 상기 단계 1)의 배양액에서 재조합 당단백질을 분리하는 단계;
를 포함하는, 반감기가 증가된 재조합 당단백질의 제조방법.
1) culturing the recombinant cell line of claim 12; And
2) separating the recombinant glycoprotein from the culture of step 1);
Wherein the recombinant glycoprotein has an increased half-life.
제 13항에 있어서, 상기 당단백질은 에리스로포이에틴, 트롬보포이에틴, 알파-안티트립신, 콜린에스테라제, 융모성 고나도트로핀, CTLA4Ig, 인자 Ⅷ(Factor Ⅷ), 감마-글루타밀트랜스퍼라아제, 과립구 콜로니 자극인자 및 황체형성호르몬으로 구성된 군으로부터 선택되는 어느 하나인, 반감기가 증가된 재조합 당단백질의 제조방법.
14. The method of claim 13, wherein the glycoprotein is selected from the group consisting of erythropoietin, thrombopoietin, alpha-antitrypsin, cholinesterase, chorionic gonadotropin, CTLA4Ig, Factor VIII, gamma-glutamyltransferase , A granulocyte colony stimulating factor, and a luteinizing hormone, wherein the half-life is increased.
제 13항에 있어서, 상기 재조합 당단백질은 삼중(Tri-) 또는 사중-안테나(Tetra-antennary) 구조가 증가한 것인, 반감기가 증가된 재조합 당단백질의 제조방법.


14. The method of claim 13, wherein the recombinant glycoprotein has an increased tri- or tetra-antennary structure.


삭제delete 삭제delete 삭제delete 삭제delete
KR1020170098912A 2016-08-08 2017-08-04 Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine KR102002790B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/KR2017/008521 WO2018030738A1 (en) 2016-08-08 2017-08-07 Method for preparation of recombinant glycoprotein having n-linked glycan antenna structure reinforced by inhibition of polylactosamine biosynthesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160100674 2016-08-08
KR20160100674 2016-08-08

Publications (2)

Publication Number Publication Date
KR20180016952A KR20180016952A (en) 2018-02-20
KR102002790B1 true KR102002790B1 (en) 2019-07-23

Family

ID=61394758

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170098912A KR102002790B1 (en) 2016-08-08 2017-08-04 Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine

Country Status (1)

Country Link
KR (1) KR102002790B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150145673A (en) * 2014-06-18 2015-12-30 한국과학기술원 Method for preparing recombinant glycoproteins with high content of sialic acid by modulating glycosphingolipid biosynthesis pathway

Also Published As

Publication number Publication date
KR20180016952A (en) 2018-02-20

Similar Documents

Publication Publication Date Title
CN106661570B (en) Preparation of engineered T cells by sleeping beauty transposons coupled with methotrexate selection
US20230295625A1 (en) Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products
KR20180059535A (en) Methods and compositions for marker-free genome modification
US20220298228A1 (en) Novel eukaryotic cells and methods for recombinantly expressing a product of interest
CN111511928A (en) Linear double-stranded DNA coupled to a single support or tag and method for preparing the same
EP3472338B1 (en) Means and methods for modifying multiple alleles
MX2011000535A (en) Novel regulatory elements.
CN112501269B (en) Method for rapidly identifying high-affinity TCR antigen cross-reactivity
KR102002790B1 (en) Method for preparing recombinant glycoproteins with improved N-glycan antennary structure by inhibiting biosynthesis of polylactosamine
WO2022159402A1 (en) Composition and method for high-multiplexed genome engineering using synthetic crispr arrays
US20230313187A1 (en) Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products
CN114672509A (en) Corynebacterium and escherichia coli dual-expression vector with high expression capacity and construction method thereof
KR102170566B1 (en) Vector for premature termination of target gene expression and strain containing the same
WO2018030738A1 (en) Method for preparation of recombinant glycoprotein having n-linked glycan antenna structure reinforced by inhibition of polylactosamine biosynthesis
KR102019992B1 (en) Isoglobotrihexosylceramide synthase knock-out cell line, and cloned embryos and cloned animals using the same
RU2733429C1 (en) Gene-therapeutic dna-vector based on gene-therapeutic dna-vector gdtt1_8nas12, carrying target hfe gene to increase expression level of this target gene, method for production and use thereof, escherichia coli strain jm110-nas/gdtt1_8nas12-hfe carrying gene-therapeutic dna vector, method for production thereof, method for industrial production of gene-therapeutic dna vector
US20060121560A1 (en) DNA fragment to promote translation reaction and method for cell-free protein synthesis system using the same
WO2018150345A1 (en) An expression vector
KR20230169221A (en) Non-viral homology-mediated end joining
CN100410382C (en) Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response
CN113166771A (en) Gene therapy DNA vector GDTT1.8NAS12 and method for obtaining the same
RU2715314C1 (en) VTvaf17-Act1-Cas9 GENE-THERAPEUTIC DNA VECTOR BASED ON VTvaf17 GENE-THERAPEUTIC DNA VECTOR CARRYING TARGET Cas9 GENE FOR HETEROLOGOUS EXPRESSION OF THIS TARGET GENE IN PLANT CELLS DURING GENOME EDITING OF PLANTS, METHOD OF PRODUCING AND USING GENE-THERAPEUTIC DNA VECTOR, STRAIN OF ESCHERICHIA COLI SCS110-AF/VTvaf17-Act1-Cas9 CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PREPARING THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR
CN101311270A (en) Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof
RU2793971C1 (en) Dna vector gdtt1.8nas12-angpt1 to increase the expression level of the target angpt1 gene, the method for its preparation and application
RU2794133C1 (en) Gdtt1.8nas12-vegfa dna vector for increasing the expression level of the target vegfa gene, method for its preparation and application

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant